<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN"  "JATS-archivearticle1-mathml3.dtd"><article article-type="research-article" dtd-version="1.2" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn pub-type="epub" publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">68558</article-id><article-id pub-id-type="doi">10.7554/eLife.68558</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Cell Biology</subject></subj-group><subj-group subj-group-type="heading"><subject>Developmental Biology</subject></subj-group></article-categories><title-group><article-title>Ciliary Hedgehog signaling regulates cell survival to build the facial midline</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-234881"><name><surname>Abrams</surname><given-names>Shaun R</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-1479-9322</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="fund3"/><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-30100"><name><surname>Reiter</surname><given-names>Jeremy F</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-6512-320X</contrib-id><email>Jeremy.Reiter@ucsf.edu</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="other" rid="fund1"/><xref ref-type="other" rid="fund2"/><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf2"/></contrib><aff id="aff1"><label>1</label><institution>Department of Biochemistry and Biophysics, Cardiovascular Research Institute</institution><addr-line><named-content content-type="city">San Francisco</named-content></addr-line><country>United States</country></aff><aff id="aff2"><label>2</label><institution>Oral and Craniofacial Sciences Program, School of Dentistry</institution><addr-line><named-content content-type="city">San Francisco</named-content></addr-line><country>United States</country></aff><aff id="aff3"><label>3</label><institution>Chan Zuckerberg Biohub</institution><addr-line><named-content content-type="city">San Francisco</named-content></addr-line><country>United States</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Devenport</surname><given-names>Danelle</given-names></name><role>Reviewing Editor</role><aff><institution>Princeton University</institution><country>United States</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Sengupta</surname><given-names>Piali</given-names></name><role>Senior Editor</role><aff><institution>Brandeis University</institution><country>United States</country></aff></contrib></contrib-group><pub-date date-type="publication" publication-format="electronic"><day>21</day><month>10</month><year>2021</year></pub-date><pub-date pub-type="collection"><year>2021</year></pub-date><volume>10</volume><elocation-id>e68558</elocation-id><history><date date-type="received" iso-8601-date="2021-03-19"><day>19</day><month>03</month><year>2021</year></date><date date-type="accepted" iso-8601-date="2021-10-20"><day>20</day><month>10</month><year>2021</year></date></history><pub-history><event><event-desc>This manuscript was published as a preprint at .</event-desc><date date-type="preprint" iso-8601-date="2021-03-18"><day>18</day><month>03</month><year>2021</year></date><self-uri content-type="preprint" xlink:href="https://doi.org/10.1101/2021.03.18.436057"/></event></pub-history><permissions><copyright-statement>Â© 2021, Abrams and Reiter</copyright-statement><copyright-year>2021</copyright-year><copyright-holder>Abrams and Reiter</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-68558-v2.pdf"/><self-uri content-type="figures-pdf" xlink:href="elife-68558-figures-v2.pdf"/><abstract><p>Craniofacial defects are among the most common phenotypes caused by ciliopathies, yet the developmental and molecular etiology of these defects is poorly understood. We investigated multiple mouse models of human ciliopathies (including <italic>Tctn2, Cc2d2a,</italic> and <italic>Tmem231</italic> mutants) and discovered that each displays hypotelorism, a narrowing of the midface. As early in development as the end of gastrulation, <italic>Tctn2</italic> mutants displayed reduced activation of the Hedgehog (HH) pathway in the prechordal plate, the head organizer. This prechordal plate defect preceded a reduction of HH pathway activation and <italic>Shh</italic> expression in the adjacent neurectoderm. Concomitant with the reduction of HH pathway activity, <italic>Tctn2</italic> mutants exhibited increased cell death in the neurectoderm and facial ectoderm, culminating in a collapse of the facial midline. Enhancing HH signaling by decreasing the gene dosage of a negative regulator of the pathway, <italic>Ptch1</italic>, decreased cell death and rescued the midface defect in both <italic>Tctn2</italic> and <italic>Cc2d2a</italic> mutants. These results reveal that ciliary HH signaling mediates communication between the prechordal plate and the neurectoderm to provide cellular survival cues essential for development of the facial midline.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>primary cilia</kwd><kwd>Hedgehog signaling</kwd><kwd>ciliopathy</kwd><kwd>dependence receptor</kwd><kwd>apoptosis</kwd><kwd>craniofacial development</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Mouse</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000072</institution-id><institution>National Institute of Dental and Craniofacial Research</institution></institution-wrap></funding-source><award-id>R01DE029454</award-id><principal-award-recipient><name><surname>Reiter</surname><given-names>Jeremy F</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000069</institution-id><institution>National Institute of Arthritis and Musculoskeletal and Skin Diseases</institution></institution-wrap></funding-source><award-id>R01AR054396</award-id><principal-award-recipient><name><surname>Reiter</surname><given-names>Jeremy F</given-names></name></principal-award-recipient></award-group><award-group id="fund3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000072</institution-id><institution>National Institute of Dental and Craniofacial Research</institution></institution-wrap></funding-source><award-id>F30DE024684</award-id><principal-award-recipient><name><surname>Abrams</surname><given-names>Shaun</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>Genetic analysis identifies the origins of midface defects in mouse models of ciliopathies, revealing a role for ciliary Hedgehog signaling in cell survival.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>Primary cilia are microtubule-based organelles present on diverse vertebrate cell types and critical for development. Primary cilia function as specialized cellular signaling organelles that coordinate multiple signaling pathways, including the Hedgehog (HH) pathway (<xref ref-type="bibr" rid="bib67">Zaghloul and Brugmann, 2011</xref>). Defects in the structure or signaling functions of cilia cause a group of human syndromes, collectively referred to as ciliopathies, which can manifest in diverse phenotypes including cystic kidneys, retinal degeneration, cognitive impairment, respiratory defects, left-right patterning defects, polydactyly, and skeletal defects (<xref ref-type="bibr" rid="bib5">Baker and Beales, 2009</xref>; <xref ref-type="bibr" rid="bib30">Hildebrandt et al., 2011</xref>; <xref ref-type="bibr" rid="bib64">Tobin and Beales, 2009</xref>). In addition to these phenotypes, craniofacial defects including cleft lip/palate, high-arched palate, jaw disorders, midface dysplasia, craniosynostosis, tongue abnormalities, abnormal dentition, and tooth number and exencephaly are observed in approximately one-third of individuals with ciliopathies (<xref ref-type="bibr" rid="bib11">Brugmann et al., 2010b</xref>; <xref ref-type="bibr" rid="bib67">Zaghloul and Brugmann, 2011</xref>). The molecular and developmental etiology of these craniofacial abnormalities remains poorly understood.</p><p>HH signaling is intimately involved in forebrain and midface development (<xref ref-type="bibr" rid="bib31">Hu and Helms, 1999</xref>; <xref ref-type="bibr" rid="bib51">Rubenstein and Beachy, 1998</xref>). In humans, inherited mutations that compromise pathway activity impair forebrain development and cause hypotelorism (<xref ref-type="bibr" rid="bib24">Fuccillo et al., 2006</xref>; <xref ref-type="bibr" rid="bib31">Hu and Helms, 1999</xref>; <xref ref-type="bibr" rid="bib32">Hu and Marcucio, 2009</xref>; <xref ref-type="bibr" rid="bib43">Marcucio et al., 2005</xref>; <xref ref-type="bibr" rid="bib45">Muenke and Beachy, 2000</xref>; <xref ref-type="bibr" rid="bib66">Young et al., 2010</xref>). For example, mutations in <italic>SHH</italic> lead to holoprosencephaly (<xref ref-type="bibr" rid="bib15">Chiang et al., 1996</xref>; <xref ref-type="bibr" rid="bib18">Cohen and Shiota, 2002</xref>). Meckel syndrome (MKS), a severe ciliopathy, is also characterized by holoprosencephaly and hypotelorism (<xref ref-type="bibr" rid="bib16">Chih et al., 2011</xref>; <xref ref-type="bibr" rid="bib22">Dowdle et al., 2011</xref>; <xref ref-type="bibr" rid="bib25">Garcia-Gonzalo et al., 2011</xref>). MKS-associated genes encode proteins that form a complex that comprises part of the transition zone, a region of the ciliary base that controls ciliogenesis and ciliary membrane protein composition in a tissue-specific manner (<xref ref-type="bibr" rid="bib16">Chih et al., 2011</xref>; <xref ref-type="bibr" rid="bib22">Dowdle et al., 2011</xref>; <xref ref-type="bibr" rid="bib25">Garcia-Gonzalo et al., 2011</xref>; <xref ref-type="bibr" rid="bib50">Roberson et al., 2015</xref>). Disruption of this transition zone complex results in the impaired ciliary localization of several membrane-associated signaling proteins including smoothened (SMO), adenylyl cyclase 3 (ADCY3), polycystin 2 (PKD2), and ARL13B (<xref ref-type="bibr" rid="bib16">Chih et al., 2011</xref>; <xref ref-type="bibr" rid="bib25">Garcia-Gonzalo et al., 2011</xref>; <xref ref-type="bibr" rid="bib50">Roberson et al., 2015</xref>).</p><p>We investigated the molecular underpinnings of forebrain and midface defects in ciliopathies utilizing multiple mouse mutants affecting the transition zone. The mutants exhibited forebrain and midface defects by E9.5, which persisted throughout development. In these mutants, the prechordal plate, an organizer of anterior head development, displayed defects in HH pathway activation at E8.0. These early prechordal plate defects attenuated <italic>Shh</italic> expression in the adjacent ventral forebrain. Decreased HH signaling increased apoptosis in the ventral neurectoderm and facial ectoderm. Surprisingly, reducing <italic>Ptch1</italic> gene dosage rescued the apoptosis and its corresponding midface defect. Thus, investigating the function of the transition zone has revealed a key role of prechordal plate-activated HH signaling in forebrain and midface cell survival. Moreover, our genetic results reveal that inhibition of PTCH1 can prevent ciliopathy-associated midface defects. Based on these mouse genetic models, we propose that the etiology of hypotelorism in human ciliopathies is a failure of the prechordal plate to induce SHH expression in the overlying ventral neuroectoderm.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>The ciliary MKS transition zone complex is essential for midline facial development</title><p>Individuals affected by developmental ciliopathies, such as Meckel, orofaciodigital, and Joubert syndromes, often display craniofacial phenotypes including holoprosencephaly and hypotelorism (<xref ref-type="bibr" rid="bib5">Baker and Beales, 2009</xref>; <xref ref-type="bibr" rid="bib22">Dowdle et al., 2011</xref>; <xref ref-type="bibr" rid="bib25">Garcia-Gonzalo et al., 2011</xref>). To explore the etiology of these craniofacial defects, we examined the craniofacial development in <italic>Tctn2</italic> mouse mutants (<xref ref-type="bibr" rid="bib25">Garcia-Gonzalo et al., 2011</xref>; <xref ref-type="bibr" rid="bib57">Shaheen et al., 2011</xref>). TCTN2 is a component of the MKS transition zone complex critical for ciliary localization of several ciliary membrane proteins, including SMO, a key ciliary mediator of HH signaling (<xref ref-type="bibr" rid="bib16">Chih et al., 2011</xref>; <xref ref-type="bibr" rid="bib19">Corbit et al., 2005</xref>; <xref ref-type="bibr" rid="bib25">Garcia-Gonzalo et al., 2011</xref>). Mutations in human <italic>TCTN2</italic> cause Meckel and Joubert syndromes (<xref ref-type="bibr" rid="bib34">Huppke et al., 2015</xref>; <xref ref-type="bibr" rid="bib52">Sang et al., 2011</xref>; <xref ref-type="bibr" rid="bib57">Shaheen et al., 2011</xref>).</p><p><italic>Tctn2</italic><sup>+/-</sup> embryos were phenotypically indistinguishable from <italic>Tctn2<sup>+/+</sup></italic> embryos (<xref ref-type="fig" rid="fig1s1">Figure 1âfigure supplement 1</xref>). In contrast, embryonic day (E) 10.5 <italic>Tctn2</italic><sup>-/-</sup> embryos exhibited an approximately 50% decrease in infranasal distance (the distance between the nasal pits, the nostril anlage) (<xref ref-type="fig" rid="fig1">Figure 1A</xref>). One day later in gestation (E11.5), <italic>Tctn2</italic><sup>-/-</sup> embryos also exhibited midfacial narrowing, including hypoplasia of the frontonasal prominence and fusion of the two maxillary prominences at the midline (<xref ref-type="fig" rid="fig1">Figure 1A</xref>). Thus, TCTN2 is essential for development of the facial midline.</p><fig-group><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>The ciliary Meckel syndrome (MKS) transition zone complex is essential for midline facial development.</title><p>Frontal view images of <italic>Tctn2</italic> (<bold>A</bold>), <italic>Cc2d2a</italic> (<bold>B</bold>), <italic>Tmem231</italic> (<bold>C</bold>) wild-type and null embryos at embryonic day (E)10.5 and E11.5. <italic>Tmem67</italic> null embryos (<bold>D</bold>) display normal midface width at E11.5. Quantification of midface width (denoted by yellow brackets) at respective timepoints was measured via one-way ANOVA followed by Tukeyâs multiple comparisons test. Data are expressed as mean, and error bars represent the standard deviation (SD) with individual data points (N) representing biological replicates (biologically distinct samples). Scale bar indicates 500 Î¼m. ns = not significant.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-68558-fig1-v2.tif"/></fig><fig id="fig1s1" position="float" specific-use="child-fig"><label>Figure 1âfigure supplement 1.</label><caption><title>The ciliary Meckel syndrome (MKS) transition zone complex is essential for midline facial development.</title><p>Reproduced frontal view images from <xref ref-type="fig" rid="fig1">Figure 1</xref> of <italic>Tctn2</italic> (<bold>A</bold>), <italic>Cc2d2a</italic> (<bold>B</bold>), <italic>Tmem231</italic> (<bold>C</bold>), wild-type and null embryos at embryonic day (E)10.5 and E11.5 with the addition of heterozygous embryos. (<bold>D</bold>) <italic>Tmem67</italic> null and wild-type E11.5 embryos reproduced from <xref ref-type="fig" rid="fig1">Figure 1</xref> with addition of heterozygous embryos. Quantification of midface width at respective timepoints measured via one-way ANOVA followed by Tukeyâs multiple comparisons test. Error bars represent the standard deviation (SD) and each data point indicates a biological replicate. Scale bar indicates 500 Î¼m.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-68558-fig1-figsupp1-v2.tif"/></fig><fig id="fig1s2" position="float" specific-use="child-fig"><label>Figure 1âfigure supplement 2.</label><caption><title>Removing TCTN2 in the neural crest does not result in hypotelorism.</title><p>(<bold>A</bold>) Frontal view images of embryonic day (E)11.5 <italic>Tctn2</italic> control (<italic>Tctn2</italic><sup>lox/-</sup>) and neural crest deletion (<italic>Wnt1</italic><sup>Cre</sup>;<italic>Tctn2</italic><sup>fl/-</sup>) embryos with corresponding midface width quantification. (<bold>B</bold>) Brightfield and fluorescent images of E11.5 <italic>Wnt1</italic><sup>Cre</sup><italic>;R26</italic><sup>EYFP/+</sup> embryos show expected pattern of Cre recombination (embryo outlined with white dotted line in B). (<bold>C</bold>) Immunofluorescence staining of E10.5 medial nasal prominence sections for ciliary membrane protein ARL13B, GFP, and epithelial marker E-cadherin (E-Cad). Dotted white line in (<bold>C</bold>) represents boundary separating epithelia and neural crest mesenchyme. Quantified data in A represents the mean with error bars indicating standard deviation (SD) and each individual data point indicates a biological replicate. Studentâs <italic>t</italic> test performed for statistical analysis of (<bold>A</bold>), ns = not significant. Scale bars indicate 500 Î¼m (<bold>A</bold>) and 10 Î¼m (<bold>C</bold>).</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-68558-fig1-figsupp2-v2.tif"/></fig></fig-group><p>To assess whether this narrowing of the facial midline is specific to TCTN2, we examined the possible involvement of two other components of the MKS complex, TMEM231 and CC2D2A, in craniofacial development. Human <italic>CC2D2A</italic> mutations cause Meckel and Joubert syndromes, and <italic>TMEM231</italic> mutations cause Meckel, Joubert, and Orofaciodigital syndromes (<xref ref-type="bibr" rid="bib46">Noor et al., 2008</xref>; <xref ref-type="bibr" rid="bib50">Roberson et al., 2015</xref>; <xref ref-type="bibr" rid="bib58">Shaheen et al., 2013</xref>; <xref ref-type="bibr" rid="bib61">Srour et al., 2012</xref>; <xref ref-type="bibr" rid="bib62">Tallila et al., 2008</xref>). Similar to <italic>Tctn2</italic> mutants, both E10.5 <italic>Cc2d2a</italic> and <italic>Tmem231</italic> mutant embryos exhibited decreased infranasal distance (<xref ref-type="fig" rid="fig1">Figure 1B and C</xref>, respectively). The similarity of the midline hypoplasia in all three transition zone mutants suggested a common etiology.</p><p>We also examined the involvement of a fourth member of the MKS complex, TMEM67, in craniofacial development. Human mutations in <italic>TMEM67</italic> also cause Meckel and Joubert syndromes (<xref ref-type="bibr" rid="bib47">Otto et al., 2009</xref>; <xref ref-type="bibr" rid="bib59">Smith et al., 2006</xref>). Mutation of mouse <italic>Tmem67</italic> causes phenotypes that are less severe than <italic>Tctn2</italic>, <italic>Tmem231</italic>, or <italic>Cc2d2a</italic> (<xref ref-type="bibr" rid="bib25">Garcia-Gonzalo et al., 2011</xref>). The mild phenotype of <italic>Tmem67</italic> mutants may be attributable to its dispensability for ciliary accumulation of HH pathway activator SMO (<xref ref-type="bibr" rid="bib25">Garcia-Gonzalo et al., 2011</xref>). Unlike <italic>Tctn2</italic>, <italic>Tmem231</italic>, and <italic>Cc2d2a</italic> mutants, <italic>Tmem67</italic> mutants did not exhibit altered infranasal distance (<xref ref-type="fig" rid="fig1">Figure 1D</xref>). Thus, some, but not all, MKS components are critical for early facial midline development.</p><p>Given the central role of the neural crest in craniofacial development as the main source of craniofacial mesenchyme (<xref ref-type="bibr" rid="bib53">Santagati and Rijli, 2003</xref>), we tested whether transition zone disruption in neural crest can account for the midline hypoplasia observed in <italic>Tctn2</italic> mutants. More specifically, we generated E11.5 <italic>Wnt1</italic><sup>cre</sup>;<italic>Tctn2</italic><sup>fl/-</sup> embryos and quantified midface width (<xref ref-type="fig" rid="fig1s2">Figure 1âfigure supplement 2A</xref>). <italic>Wnt1</italic><sup>cre</sup> induces recombination throughout the neural crest, and conditional deletion of <italic>Tctn2</italic> in the neural crest abrogated ARL13B localization to cilia (<xref ref-type="fig" rid="fig1s2">Figure 1âfigure supplement 2B</xref>,C). Interestingly, removing TCTN2 from the neural crest did not cause hypotelorism. These results indicate that altered transition zone function in the neural crest is not the etiology of midline hypoplasia. Therefore, we investigated functions of TCTN2 in the prechordal plate, an early organizing center also critical for the development of anterior head structures.</p></sec><sec id="s2-2"><title><italic>Tctn2</italic> mutants exhibit defects in prechordal plate differentiation soon after gastrulation</title><p>As <italic>Tctn2</italic>, <italic>Cc2d2a</italic>, and <italic>Tmem231</italic> mutants all displayed facial midline defects at midgestation, we hypothesized that they shared a role in a patterning event early in craniofacial development. One organizing center critical for early forebrain and craniofacial development is the prechordal plate (<xref ref-type="bibr" rid="bib12">Camus et al., 2000</xref>; <xref ref-type="bibr" rid="bib38">Kiecker and Niehrs, 2001</xref>; <xref ref-type="bibr" rid="bib45">Muenke and Beachy, 2000</xref>; <xref ref-type="bibr" rid="bib51">Rubenstein and Beachy, 1998</xref>; <xref ref-type="bibr" rid="bib60">Som et al., 2014</xref>). The prechordal plate is the anterior-most midline mesendoderm, immediately anterior to the notochord and in contact with the overlying ectoderm. The homeobox gene <italic>Goosecoid</italic> (<italic>Gsc</italic>) is specifically expressed in the prechordal plate at E8.0 and is a marker of differentiation in this organizing center (<xref ref-type="bibr" rid="bib6">Belo et al., 1998</xref>; <xref ref-type="bibr" rid="bib35">IzpisÃºa-Belmonte et al., 1993</xref>). In contrast, <italic>Shh</italic> and <italic>Brachyury</italic> (<italic>T</italic>) are expressed at E8.0 in both the prechordal plate and notochord and are critical for prechordal plate induction (<xref ref-type="bibr" rid="bib3">Aoto et al., 2009</xref>). Previous work demonstrated that surgical removal of the rat prechordal plate results in midface defects (<xref ref-type="bibr" rid="bib3">Aoto et al., 2009</xref>) that seemed similar to those of the mouse <italic>Tctn2</italic>, <italic>Cc2d2a</italic>, and <italic>Tmem231</italic> mouse mutants.</p><p>Therefore, we analyzed the prechordal plate of <italic>Tctn2</italic> mutants by examining the expression of prechordal plate differentiation marker <italic>Gsc</italic> and induction markers <italic>Shh</italic> and <italic>T. Gsc</italic> is expressed specifically in the prechordal mesoderm, while <italic>Shh</italic> and <italic>T</italic> are expressed in both the prechordal mesoderm and notochord (<xref ref-type="bibr" rid="bib20">Dale et al., 1997</xref>; <xref ref-type="bibr" rid="bib29">Herrmann, 1991</xref>; <xref ref-type="bibr" rid="bib56">Schulte-Merker et al., 1994</xref>). In situ hybridization analysis revealed that in <italic>Tctn2</italic> mutants, <italic>Shh</italic> and <italic>T</italic> expression in the prechordal plate and notochord were unaffected (<xref ref-type="fig" rid="fig2">Figure 2A</xref>). Therefore, TCTN2 is not essential for prechordal plate specification. In contrast, <italic>Tctn2</italic> mutants exhibited abrogated <italic>Gsc</italic> expression in the prechordal plate (<xref ref-type="fig" rid="fig2">Figure 2B</xref>), indicating that TCTN2 is critical for prechordal plate differentiation.</p><fig id="fig2" position="float"><label>Figure 2.</label><caption><title><italic>Tctn2</italic> mutants exhibit defects in prechordal plate differentiation soon after gastrulation.</title><p>(<bold>A</bold>) Whole mount in situ hybridization (WM-ISH) of embryonic day (E)8.0 embryos for axial mesendoderm markers <italic>Shh </italic>and <italic>Brachyury</italic> (<italic>T</italic>). (<bold>B</bold>) WM-ISH of E8.0 embryos for prechordal plate marker <italic>Goosecoid</italic> (<italic>Gsc</italic>) and Hedgehog (HH) pathway target <italic>Gli1</italic>. (<bold>C</bold>) Whole mount immunofluorecence staining for the prechordal plate transcription factor FOXA2, cilia marker acetylated tubulin (TUB<sup>Ac</sup>), basal body marker gamma tubulin (Î³-TUB), and ciliary membrane protein ARL13B in E8.0 embryos. Middle panel in C is magnified region in top panel highlighted by dotted rectangle and rotated 90 degrees. Scale bar in AâB indicates 0.2 mm, C (top panel) is 100 Î¼m, C (middle and bottom panels) is 10 Î¼m.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-68558-fig2-v2.tif"/></fig><p>The transition zone is critical for HH signaling, and one HH protein, SHH, is essential for <italic>Gsc</italic> expression in the prechordal plate (<xref ref-type="bibr" rid="bib3">Aoto et al., 2009</xref>; <xref ref-type="bibr" rid="bib16">Chih et al., 2011</xref>; <xref ref-type="bibr" rid="bib25">Garcia-Gonzalo et al., 2011</xref>). Therefore, we investigated whether TCTN2 is required for HH signaling in the prechordal plate by examining the expression of the transcriptional target <italic>Gli1. Tctn2</italic> mutants exhibited reduced <italic>Gli1</italic> expression throughout the axial mesendoderm, including the prechordal plate (<xref ref-type="fig" rid="fig2">Figure 2B</xref>). These results indicate that TCTN2 is dispensable for the formation of the prechordal plate, but is required for midline signaling by SHH to induce <italic>Gsc</italic> expression in this organizing center.</p><p>TCTN2 and other members of the MKS complex are required for proper cilia formation in some tissues but not in others (<xref ref-type="bibr" rid="bib25">Garcia-Gonzalo et al., 2011</xref>). Therefore, we examined whether TCTN2 is required for ciliogenesis in the prechordal plate. The prechordal plate expresses FOXA2 (<xref ref-type="bibr" rid="bib37">Jin et al., 2001</xref>; <xref ref-type="fig" rid="fig2">Figure 2C</xref>). Co-immunostaining embryos for FOXA2 and acetylated tubulin (TUB<sup>Ac</sup>), a marker of cilia, revealed that <italic>Tctn2</italic> mutants did not display decreased ciliogenesis in the E8.5 prechordal plate (<xref ref-type="fig" rid="fig2">Figure 2C</xref>, middle panel). Previous studies have shown that <italic>Tctn1</italic> is expressed in the ventral epithelium of the node of a six-somite stage embryo and in the neural tube, notochord, gut epithelium, and somites at E9.5 (<xref ref-type="bibr" rid="bib49">Reiter, 2006</xref>). <italic>Tctn2</italic> is similarly broadly expressed during mouse development (<xref ref-type="bibr" rid="bib21">Diez-Roux et al., 2011</xref>; <xref ref-type="bibr" rid="bib42">Magdaleno et al., 2006</xref>), and <italic>CC2D2A</italic> is broadly expressed during human development (<xref ref-type="bibr" rid="bib44">Mougou-Zerelli et al., 2009</xref>).</p><p>In cell types in which the MKS complex is dispensable for ciliogenesis, like neural progenitors, it is required for localization of ARL13B to cilia (<xref ref-type="bibr" rid="bib25">Garcia-Gonzalo et al., 2011</xref>). Therefore, we examined ARL13B localization in E8.0 control embryos and <italic>Tctn2</italic> mutants and discovered that ARL13B localization to prechordal plate cilia was attenuated without TCTN2 (<xref ref-type="fig" rid="fig2">Figure 2C</xref>, bottom panel). Thus, TCTN2 is not required for ciliogenesis in the prechordal plate, but does control ciliary composition.</p></sec><sec id="s2-3"><title><italic>Tctn2</italic> mutants display decreased HH signaling in the ventral telencephalon</title><p>The axial mesendoderm helps pattern the overlying neurectoderm (<xref ref-type="bibr" rid="bib2">Anderson and Stern, 2016</xref>; <xref ref-type="bibr" rid="bib51">Rubenstein and Beachy, 1998</xref>). In the rostral embryo, the prechordal plate patterns the overlying ventral telencephalon via SHH (<xref ref-type="bibr" rid="bib15">Chiang et al., 1996</xref>; <xref ref-type="bibr" rid="bib65">Xavier et al., 2016</xref>). As extirpation of the prechordal plate results in decreased SHH activity in the basal telencephalon (<xref ref-type="bibr" rid="bib3">Aoto et al., 2009</xref>; <xref ref-type="bibr" rid="bib4">Aoto and Trainor, 2015</xref>), we investigated whether the prechordal plate defects observed in <italic>Tctn2</italic> mutants result in mispatterning of the ventral telencephalon. Although <italic>Shh</italic> expression in the notochord was unaffected in <italic>Tctn2</italic> mutants at E8.75, it was severely reduced in the ventral telencephalon (<xref ref-type="fig" rid="fig3">Figure 3A</xref>). This reduced expression of <italic>Shh</italic> in the ventral telencephalon persisted at E9.5 (<xref ref-type="fig" rid="fig3">Figure 3A</xref>). These results are concordant with previous findings that mutations in genes encoding other transition zone components disrupt brain development, resulting in holoprosencephaly, reduced telencephalon size, or exencephaly (<xref ref-type="bibr" rid="bib22">Dowdle et al., 2011</xref>; <xref ref-type="bibr" rid="bib25">Garcia-Gonzalo et al., 2011</xref>; <xref ref-type="bibr" rid="bib49">Reiter, 2006</xref>).</p><fig id="fig3" position="float"><label>Figure 3.</label><caption><title><italic>Tctn2</italic> mutants display decreased Hedgehog (HH) signaling in the ventral telencephalon.</title><p>Whole mount in situ hybridization (WM-ISH) for <italic>Shh</italic> in <italic>Tctn2</italic> control and mutant embryos at embryonic day (E)8.75 and E9.5 (<bold>A</bold>) show reduced expression in the ventral telencephalons (arrowheads) of mutant embryos . WM-ISH for HH pathway targets <italic>Ptch1</italic> and <italic>Gli1</italic> also show reduced expression in the ventral telencephalon in <italic>Tctn2</italic> mutants (<bold>B</bold>, arrowheads). Quantitative real-time polymerase chain reaction (RT-qPCR) analysis of RNA transcripts isolated from E8.5 and E9.5 <italic>Tctn2</italic> control and mutant heads (<bold>C</bold> and <bold>D</bold>, respectively) show reduced levels of <italic>Gli1</italic>, <italic>Ptch1</italic>, and <italic>Shh</italic> transcripts in the absence of TCTN2, consistent with WM-ISH results. Data in C, D represent mean, and error bar represents the standard deviation (SD). Sample size in C and D indicated with 3-4 biological replicates per assay. Studentâs <italic>t</italic> test performed for statistical analysis. Scale bar indicates 0.5 mm.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-68558-fig3-v2.tif"/></fig><p>To assess whether HH pathway activity was compromised by the absence of TCTN2, we assessed the expression of the HH transcriptional targets <italic>Gli1</italic> and <italic>Ptch1</italic>. Whole mount in situ hybridization (WM-ISH) of <italic>Tctn2</italic> mutants revealed dramatically reduced or absent expression of both <italic>Gli1</italic> and <italic>Ptch1</italic>, especially in the basal forebrain (<xref ref-type="fig" rid="fig3">Figure 3B</xref>). Consistent with the WM-ISH data, quantitative real-time polymerase chain reaction (RT-qPCR) analysis of E8.5 (<xref ref-type="fig" rid="fig3">Figure 3C</xref>) and E9.5 (<xref ref-type="fig" rid="fig3">Figure 3D</xref>) <italic>Tctn2</italic> mutant heads also revealed decreased expression of <italic>Shh, Ptch1</italic>, and <italic>Gli1,</italic> revealing that <italic>Tctn2</italic> mutants exhibit both an early defect in prechordal plate differentiation and a defect in HH signaling in the adjacent neurectoderm.</p></sec><sec id="s2-4"><title>TCTN2 protects neurectoderm and facial ectoderm from apoptosis</title><p>In the developing craniofacial complex, SHH induces cell proliferation (<xref ref-type="bibr" rid="bib31">Hu and Helms, 1999</xref>; <xref ref-type="bibr" rid="bib33">Hu et al., 2015</xref>). Therefore, we assessed if the reduction in facial midline width in <italic>Tctn2</italic> mutants was due to decreased cell proliferation. More specifically, we measured cell proliferation by quantitating phospho-histone H3 (pHH3) in the components of the craniofacial complex â the forebrain, hindbrain, facial ectoderm, and mesenchyme (<xref ref-type="fig" rid="fig4">Figure 4A and B</xref>). <italic>Tctn2</italic> mutants showed no differences in amount or spatial distribution of cell proliferation.</p><fig-group><fig id="fig4" position="float"><label>Figure 4.</label><caption><title>TCTN2 protects the neurectoderm and facial ectoderm from apoptosis.</title><p>Immunostaining for proliferation marker phospho-histone H3 (pHH3) in transverse sections of <italic>Tctn2</italic> control and mutant embryonic day (E9.5) embryos (<bold>A</bold>) with corresponding quantification (<bold>B</bold>). (<bold>C</bold>) TUNEL staining for analysis of apoptosis in <italic>Tctn2</italic> E9.5 embryos with corresponding quantification (<bold>D</bold>). (<bold>E</bold>) Immunostaining for intrinsic apoptotic pathway components cleaved-caspase-3 and cleaved-caspase-9 in <italic>Tctn2</italic> control and mutant E9.5 embryos. Quantified data represent N = 3 biological replicates (biologically distinct samples) with a minimum of two sections analyzed per sample. Studentâs <italic>t</italic> test performed for statistical analysis. Data in B, D represent the mean, and error bars represent the standard deviation (SD). Scale bar indicates 100 Î¼m. ns = not significant.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-68558-fig4-v2.tif"/></fig><fig id="fig4s1" position="float" specific-use="child-fig"><label>Figure 4âfigure supplement 1.</label><caption><title>Deletion of <italic>Tctn2</italic> in the prechordal plate by <italic>Isl1</italic><sup>Cre</sup>, neurectoderm by <italic>Sox1</italic><sup>Cre</sup>, facial ectoderm by <italic>Tcfap2a</italic><sup>Cre</sup>, or forebrain and facial ectoderm by <italic>Foxg1</italic><sup>Cre</sup> does not result in hypotelorism.</title><p>(<bold>A</bold>) Analysis of <italic>Isl1</italic><sup>Cre</sup> recombination pattern at E8.5 and E11.5 using the <italic>R26</italic><sup>mTmG</sup> reporter shows robust recombination in the prechordal plate and endodermal derivatives at respective timepoints. (<bold>B</bold>) Analysis of <italic>Sox1</italic><sup>Cre</sup> recombination pattern at E8.5, E9.5, and E11.5 using the <italic>R26</italic><sup>mTmG</sup> reporter shows early recombination in the neural folds at E8.5 followed by robust recombination throughout the neurectoderm at E9.5 and E11.5. (<bold>C</bold>) Frontal view images of E11.5 control (<italic>Tctn2</italic><sup>fl/-</sup>) and mutant (<italic>Isl1</italic><sup>Cre</sup><italic>;Tctn2</italic><sup>fl/-</sup>) embryos with corresponding midface width quantification. (<bold>D</bold>) Frontal view images of E11.5 control (<italic>Tctn2</italic><sup>fl/-</sup>) and neurectoderm-specific <italic>Tctn2</italic> mutant (<italic>Sox1</italic><sup>Cre</sup><italic>;Tctn2</italic><sup>fl/-</sup>) embryos with corresponding midface width quantification. (<bold>E</bold>) Analysis of <italic>Tcfap2a</italic><sup>Cre</sup> recombination pattern at E11.5 using the <italic>R26</italic><sup>EYFP</sup> reporter shows robust recombination in the facial ectoderm as evidenced by colocalization with epithelial marker E-cadherin (E-Cad). (<bold>F</bold>) Analysis of <italic>Foxg1</italic><sup>Cre</sup> recombination pattern at E11.5 using the <italic>R26</italic><sup>EYFP</sup> reporter shows expected robust recombination in the forebrain and facial ectoderm at E11.5. (<bold>G</bold>) Frontal view images of E11.5 control (<italic>Tctn2</italic><sup>fl/-</sup>) and facial ectoderm deletion (<italic>Tcfap2a</italic><sup>Cre</sup><italic>;Tctn2</italic><sup>fl/-</sup>) embryos with corresponding midface width quantification. (<bold>H</bold>) Frontal view images of E11.5 control (<italic>Tctn2</italic><sup>fl/-</sup>) and forebrain/facial ectoderm-specific <italic>Tctn2</italic> deletion (<italic>Foxg1</italic><sup>Cre</sup><italic>;Tctn2</italic><sup>fl/-</sup>) embryos with corresponding midface width quantification. Dotted line in E indicates approximate section through midface for immunofluorescence images in E. Dotted white line in F indicates embryo outline. Quantified data in C, D, G, and H represent the mean with error bars indicating standard deviation (SD) and each individual data point indicates a biological replicate. Studentâs <italic>t</italic> test performed for statistical analysis of C, D, G, and H. Scale bars indicate 100 Î¼m in B, 500 Î¼m in C, D, G, and H. ns = not significant.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-68558-fig4-figsupp1-v2.tif"/></fig><fig id="fig4s2" position="float" specific-use="child-fig"><label>Figure 4âfigure supplement 2.</label><caption><title>Residual TCTN2 function through persistent ARL13B ciliary localization in TCTN2 conditional mutants.</title><p>(<bold>A</bold>) Analysis of <italic>Tctn2</italic> deletion in the prechordal plate of embryonic day (E)8.5 <italic>Isl1</italic><sup>Cre</sup>;<italic>Tctn2</italic><sup>fl/-</sup> embryos through ciliary localization of ARL13B indicates residual TCTN2 function remains at this early timepoint despite reporter recombination. (<bold>B</bold>) Analysis of <italic>Tctn2</italic> deletion in the neurectoderm of E9.5 <italic>Sox1</italic><sup>Cre</sup>;<italic>Tctn2</italic><sup>fl/-</sup> embryos through ciliary localization of ARL13B in the forebrain (top panels) and hindbrain (bottom panels) indicates residual TCTN2 function remains at this early timepoint despite robust reporter recombination. (<bold>C</bold>) Analysis of <italic>Tctn2</italic> deletion in the facial ectoderm of E11.5 <italic>Tcfap2a</italic><sup>Cre</sup><italic>;Tctn2</italic><sup>fl/-</sup> embryos through ciliary localization of ARL13B indicates residual TCTN2 function remains at this timepoint as ARL13B accumulation in cilia persists in the facial ectoderm of <italic>Tcfap2a</italic><sup>Cre</sup><italic>;Tctn2</italic><sup>fl/-</sup> mutants. (<bold>D</bold>) Immunofluorescence staining of E11.5 neural tube sections for ciliary membrane protein ARL13B, basal body marker gamma tubulin (Î³TUB), and Î±-GFP for readout of reporter recombination shows loss of TCTN2 function in <italic>Foxg1</italic><sup>Cre</sup>;<italic>Tctn2</italic><sup>fl/-</sup> embryos through loss of ARL13B ciliary accumulation. Low-magnification images in A and B indicate 100 Î¼m, and high-magnification images in A (bottom panels), B (right panels), C, and D indicate 10 Î¼m. ns = not significant.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-68558-fig4-figsupp2-v2.tif"/></fig></fig-group><p>In other developmental contexts, HH signaling promotes cell survival (<xref ref-type="bibr" rid="bib1">Ahlgren and Bronner-Fraser, 1999</xref>; <xref ref-type="bibr" rid="bib3">Aoto et al., 2009</xref>; <xref ref-type="bibr" rid="bib4">Aoto and Trainor, 2015</xref>; <xref ref-type="bibr" rid="bib39">Litingtung and Chiang, 2000</xref>). Therefore, we assessed apoptosis in the craniofacial complex of <italic>Tctn2</italic> mutants. Quantification of TUNEL staining revealed that apoptosis was increased in the neurectoderm, facial ectoderm, and mesenchyme of <italic>Tctn2</italic> mutants compared to controls, and most dramatically in the ventral telencephalon (<xref ref-type="fig" rid="fig4">Figure 4C and D</xref>). To further test whether apoptosis is increased in the absence of TCTN2, we stained for activators of the intrinsic apoptotic pathway, cleaved-caspase-3 and caspase-9 (activated CASP3 and CASP9). Both activated CASP3 and CASP9 were increased in the ventral telencephalon, facial ectoderm, and mesenchyme of <italic>Tctn2</italic> mutants at E9.5 (<xref ref-type="fig" rid="fig4">Figure 4E</xref>). These data indicate that TCTN2 is required to protect against cell death, but does not affect proliferation, in the neurectoderm, non-neural ectoderm and neural crest mesenchyme. As SHH also protects neurectoderm from apoptosis (<xref ref-type="bibr" rid="bib63">Thibert et al., 2003</xref>), we propose that TCTN2 mediates cell survival by promoting HH signaling and that the increase in cell death in the neurectoderm, mesenchyme and facial ectoderm underlies the midline hypoplasia in transition zone mutants.</p><p>Our finding that selective disruption of transition zone function in the neural crest did not contribute to midline growth (<xref ref-type="fig" rid="fig1s2">Figure 1âfigure supplement 2</xref>) coupled with increased apoptosis in the <italic>Tctn2</italic> mutant, neurectoderm and facial ectoderm (<xref ref-type="fig" rid="fig4">Figure 4CâD</xref>) led us to investigate where TCTN2 is required to coordinate midline facial development. <italic>Isl1</italic><sup>Cre</sup> induced robust reporter recombination in the prechordal plate at E8.5 (<xref ref-type="fig" rid="fig4s1">Figure 4âfigure supplement 1A</xref>) and <italic>Sox1</italic><sup>Cre</sup> induced recombination in the neuroectoderm by E9.5 (<xref ref-type="fig" rid="fig4s1">Figure 4âfigure supplement 1B</xref>). Using <italic>Isl1<sup>Cre</sup></italic> and <italic>Sox1<sup>Cre</sup></italic>, we removed <italic>Tctn2</italic> from the prechordal plate or neurectoderm, respectively. Both <italic>Isl1</italic><sup>Cre</sup>;<italic>Tctn2</italic><sup>fl/-</sup> and <italic>Sox1</italic><sup>Cre</sup>;<italic>Tctn2</italic><sup>fl/-</sup> embryos displayed no decrease in midline width at E11.5 (<xref ref-type="fig" rid="fig4s1">Figure 4âfigure supplement 1C and D</xref>).</p><p>Similarly, we investigated the function of TCTN2 in the facial ectoderm and telencephalon. <italic>Tcfap2a</italic><sup>Cre</sup> and <italic>Foxg1</italic><sup>Cre</sup> activated recombination in the facial ectoderm or telencephalon and ectoderm, respectively (<xref ref-type="fig" rid="fig4s1">Figure 4âfigure supplement 1E</xref>, F). Both <italic>Tcfap2a</italic><sup>Cre</sup><italic>;Tctn2</italic><sup>fl/-</sup> and <italic>Foxg1</italic><sup>Cre</sup>;<italic>Tctn2</italic><sup>fl/-</sup> embryos displayed no decrease in midline width at E11.5 (<xref ref-type="fig" rid="fig4s1">Figure 4âfigure supplement 1G</xref>, H).</p><p>Analysis of ARL13B localization to cilia at E8.5 and E9.5 in the prechordal plate and neurectoderm in <italic>Isl1</italic><sup>Cre</sup>;<italic>Tctn2</italic><sup>fl/-</sup> and <italic>Sox1</italic><sup>Cre</sup>;<italic>Tctn2</italic><sup>fl/-</sup> embryos, respectively, revealed that there was no alteration in ciliogenesis or ciliary localization of ARL13B (<xref ref-type="fig" rid="fig4s2">Figure 4âfigure supplement 2A and B</xref>). Analysis of ciliary ARL13B localization in the ectoderm of E11.5 <italic>Tcfap2a</italic><sup>Cre</sup><italic>;Tctn2</italic><sup>fl/-</sup> mutants similarly revealed persistent ARL13B localization to cilia (<xref ref-type="fig" rid="fig4s2">Figure 4âfigure supplement 2C</xref>). In contrast, <italic>Foxg1</italic><sup>Cre</sup>;<italic>Tctn2</italic><sup>fl/-</sup> mutants exhibited loss of ARL13B ciliary localization in the basal telencephalon at E11.5 (<xref ref-type="fig" rid="fig4s2">Figure 4âfigure supplement 2D</xref>). These results indicate that <italic>Tctn2</italic> conditional deletion in either the prechordal plate, neurectoderm, facial ectoderm, or forebrain individually fails to recapitulate the midline narrowing observed in <italic>Tctn2</italic><sup>-/-</sup> embryos. However, the persistence of ARL13B at cilia suggests that TCTN2 function persists for some time after recombination or TCTN2 functions in the prechordal plate, neurectoderm and facial ectoderm may be important for facial development.</p></sec><sec id="s2-5"><title>Reducing <italic>Ptch1</italic> gene dosage rescues the facial midline defect in transition zone mutants</title><p>To assess whether decreased HH signaling is not just correlated with midfacial hypoplasia in transition zone mutants, but is causative, we investigated whether modulating the HH pathway could rescue the midface defects. We employed a strategy targeting <italic>Ptch1</italic>, a negative regulator of the HH pathway, by generating <italic>Tctn2</italic><sup>-/-</sup>;<italic>Ptch1</italic><sup>+/-</sup> embryos and comparing them to <italic>Tctn2</italic><sup>-/-</sup>;<italic>Ptch1</italic><sup>+/+</sup> embryos. Surprisingly, removing a single allele of <italic>Ptch1</italic> in <italic>Tctn2</italic> mutants restored midface width at E11.5 (<xref ref-type="fig" rid="fig5">Figure 5A and B</xref>).</p><fig id="fig5" position="float"><label>Figure 5.</label><caption><title>Reducing <italic>Ptch1</italic> gene dosage rescues the facial midline defect in transition zone mutants.</title><p>(<bold>A</bold>) Frontal images of <italic>Tctn2</italic> wild-type, mutant, and <italic>Ptch1</italic><sup>+/-</sup> rescue embryonic day (E)11.5 embryos with corresponding midline width quantification (<bold>B</bold>). (<bold>C</bold>) Frontal images of <italic>Cc2d2a</italic> wild-type, mutant, and <italic>Ptch1</italic><sup>+/-</sup> rescue E11.5 embryos with corresponding midline width quantification (<bold>D</bold>). (<bold>E</bold>) TUNEL assay sections of E9.5 <italic>Tctn2</italic> wild-type, mutant, and <italic>Ptch1</italic><sup>+/-</sup> rescue with corresponding quantification (<bold>F</bold>). (<bold>G</bold>) Whole mount in situ hybridization (WM-ISH) of E9.5 <italic>Tctn2</italic> wild-type, mutant, and <italic>Ptch1</italic><sup>+/-</sup> rescue embryos for <italic>Shh</italic> and <italic>Gli1</italic>. Quantified data represent N = 3 biological replicates (biologically distinct samples) with a minimum of two sections analyzed per sample. Data in B, D, F represent the mean, and error bars represent the standard deviation (SD). For statistical analysis, one-way ANOVA was performed with Tukeyâs multiple comparison test. Scale bars indicate 500 Î¼m (<bold>A, C, G</bold>) and 100 Î¼m (<bold>E</bold>).</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-68558-fig5-v2.tif"/></fig><p>To assess whether removing a single allele of <italic>Ptch1</italic> restores midface width in other transition zone mutants, we generated <italic>Cc2d2a</italic><sup>-/-</sup>;<italic>Ptch1</italic><sup>+/-</sup> and <italic>Cc2d2a</italic><sup>-/-</sup>;<italic>Ptch1</italic><sup>+/+</sup> embryos. As with <italic>Tctn2</italic>, removing a single allele of <italic>Ptch1</italic> restored midface width in <italic>Cc2d2a</italic> mutants (<xref ref-type="fig" rid="fig5">Figure 5C and D</xref>). Thus, reducing <italic>Ptch1</italic> gene dosage rescues midface expansion in both models of ciliopathy-associated hypoplasia.</p><p>As we had hypothesized that increased apoptosis underlay the midface hypoplasia of <italic>Tctn2</italic><sup>-/-</sup>;<italic>Ptch1</italic><sup>+/+</sup> embryos, we assessed apoptosis in <italic>Tctn2</italic><sup>-/-</sup>;<italic>Ptch1</italic><sup>+/-</sup> embryos via TUNEL staining. <italic>Tctn2<sup>-/-</sup>;Ptch1<sup>+/-</sup></italic> exhibited less apoptosis than <italic>Tctn2</italic><sup>-/-</sup>;<italic>Ptch1</italic><sup>+/+</sup> embryos, with a restriction of apoptosis in the ventral telencephalon (<xref ref-type="fig" rid="fig5">Figure 5EâF</xref>). These results bolster the hypothesis that increased midline apoptosis accounts for the midline hypoplasia of transition zone mutants.</p><p>As genes encoding transition zone MKS components are epistatic to <italic>Ptch1</italic> (<xref ref-type="bibr" rid="bib49">Reiter, 2006</xref>), we pondered how reducing <italic>Ptch1</italic> gene dosage restored facial midline development to transition zone MKS component mutants. The best studied role for PTCH1 is in repression of the HH signal transduction pathway. Therefore, we examined HH signal transduction pathway activity in <italic>Tctn2<sup>-/-</sup>;Ptch1<sup>+/+</sup></italic> and <italic>Tctn2<sup>-/-</sup>;Ptch1<sup>+/-</sup></italic> embryos. WM-ISH revealed that expression of neither <italic>Shh</italic> nor <italic>Gli1</italic> was increased in the ventral telencephalons of <italic>Tctn2<sup>-/-</sup>;Ptch1<sup>+/-</sup></italic> in comparison to <italic>Tctn2<sup>-/-</sup>;Ptch1<sup>+/+</sup></italic> embryos (<xref ref-type="fig" rid="fig5">Figure 5G</xref>). Thus, the restoration of midface growth by reduction of <italic>Ptch1</italic> gene dosage is not due to a restoration of HH signal transduction.</p><p>In addition to its role in regulating HH signal transduction, PTCH1 exhibits pro-apoptotic activity in vitro (<xref ref-type="bibr" rid="bib63">Thibert et al., 2003</xref>). In the absence of ligand, PTCH1 C-terminal domain is cleaved and binds scaffolding proteins TUCAN1 and DRAL to recruit caspase-9 and activate caspase-3, resulting in apoptosis. The colocalization of another PTCH1-binding protein that regulates apoptosis, X-linked inhibitory apoptosis protein (XIAP), with PTCH1 at cilia (<xref ref-type="bibr" rid="bib4">Aoto and Trainor, 2015</xref>), raises the possibility that PTCH1 cleavage occurs at the primary cilium to induce apoptosis. In addition, PTCH1 may induce apoptosis at the plasma membrane. As reducing <italic>Ptch1</italic> gene dosage reduces apoptosis without increasing HH signal transduction in <italic>Tctn2</italic> mutants, our data supports a model in which the PTCH1-mediated death of the midline neurectoderm, facial ectoderm, and neural crest-derived mesenchyme, and not alterations in HH signal transduction within those cells, is the etiology of midface defects in transition zone mutants. Taken together, these results suggest a working model for how ciliary HH signaling regulates midface development.</p><p>In wild-type embryos, HH signaling within the prechordal plate is critical for <italic>Gsc</italic> expression and the induction of <italic>Shh</italic> in the adjacent neurectoderm and inhibition of apoptosis (<xref ref-type="fig" rid="fig6">Figure 6A</xref>). In transition zone mutants, defects in prechordal plate signaling cause reduced SHH in the neurectoderm, resulting in increased PTCH1-mediated cell death and midline collapse (<xref ref-type="fig" rid="fig6">Figure 6B</xref>). In transition zone mutants lacking a single allele of <italic>Ptch1</italic>, reduced SHH in the neurectoderm persists, but the attenuated PTCH1 is no longer sufficient to induce extensive cell death, allowing for normal midline facial development (<xref ref-type="fig" rid="fig6">Figure 6C</xref>).</p><fig id="fig6" position="float"><label>Figure 6.</label><caption><title>Model for transition zone coordination of facial midline development.</title><p>(<bold>A</bold>) In wild-type embryos, the transition zone complex mediates signaling in the prechordal plate and Hedgehog (HH) pathway activation in the adjacent neurectoderm to at allow for cell survival and normal midline development. (<bold>B</bold>) In transition zone mutants, disrupted signaling in the prechordal plate results in reduced <italic>Shh</italic> and HH pathway activation in the neurectoderm resulting in increased cell death and corresponding collapse of the facial midline. (<bold>C</bold>) In transition zone mutants with <italic>Ptch1</italic> haploinsufficiency (<italic>Ptch1</italic> rescue), reduced cell death allows for normal midface development despite persistent reduction of <italic>Shh</italic> and HH pathway activation in the neurectoderm.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-68558-fig6-v2.tif"/></fig></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>Using a combination of genetic, developmental, and biochemical techniques, we have identified a mechanism by which disruption of MKS transition zone proteins (TCTN2, CC2D2A, and TMEM231) results in midline hypoplasia and hypotelorism. We traced the origin of the molecular defect contributing to the midline phenotype to the prechordal plate, defects in which resulted in reduced HH pathway activation and cell survival in the adjacent neurectoderm and facial midline collapse. We uncovered <italic>Ptch1</italic> gene dosage as a key mediator of cell survival in the facial midline of transition zone mutants, as loss of a single allele of <italic>Ptch1</italic> rescued cell survival and midline development in <italic>Tctn2</italic> and <italic>Cc2d2a</italic> mutants. Together, these results reveal a new paradigm whereby primary cilia mediate signal crosstalk from the prechordal plate to the adjacent neurectoderm to promote cell survival, without which the facial midline collapses and hypotelorism results.</p><p>Different ciliopathies are associated with either narrowing or expansion of the facial midline (hypotelorism or hypertelorism) (<xref ref-type="bibr" rid="bib54">Schock et al., 2015</xref>; <xref ref-type="bibr" rid="bib67">Zaghloul and Brugmann, 2011</xref>). Severe ciliopathies associated with perinatal lethality, such as MKS, can present with hypotelorism or hypertelorism while other ciliopathies such as Joubert syndrome typically present with hypertelorism (<xref ref-type="bibr" rid="bib11">Brugmann et al., 2010b</xref>; <xref ref-type="bibr" rid="bib41">MacRae et al., 1972</xref>; <xref ref-type="bibr" rid="bib55">Schock and Brugmann, 2017</xref>). How disruption of ciliary functions can give rise to these opposing phenotypes has been an active area of interest. Hypertelorism is attributable to roles for cilia in promoting GLI3 repressor formation in neural crest cells (<xref ref-type="bibr" rid="bib10">Brugmann et al., 2010a</xref>; <xref ref-type="bibr" rid="bib13">Chang et al., 2014</xref>; <xref ref-type="bibr" rid="bib14">Chang et al., 2016</xref>; <xref ref-type="bibr" rid="bib40">Liu et al., 2014</xref>). Our work implicates a distinct etiology of hypotelorism: rather than involving neural crest, midline hypoplasia can be caused by defects in the ciliary transition zone in the prechordal plate.</p><p>The earliest alteration we detected in <italic>Tctn2</italic><sup>-/-</sup> signaling centers that regulate craniofacial development was in the prechordal plate at the end of gastrulation. TCTN2 was dispensable for the expression of <italic>Shh</italic> and <italic>T</italic> in the prechordal plate, indicating that induction and specification of the prechordal plate were not dependent on transition zone function. In contrast, TCTN2 was essential for prechordal plate expression of <italic>Gli1</italic> and <italic>Gsc</italic>. In tissues such as the limb bud, TCTN2 is dispensable for ciliogenesis but critical for ciliary HH signaling and the induction of HH target genes such as <italic>Gli1</italic> (<xref ref-type="bibr" rid="bib16">Chih et al., 2011</xref>; <xref ref-type="bibr" rid="bib22">Dowdle et al., 2011</xref>; <xref ref-type="bibr" rid="bib25">Garcia-Gonzalo et al., 2011</xref>). We found that, similarly in the prechordal plate, TCTN2 is dispensable for ciliogenesis but critical for induction of <italic>Gli1</italic>.</p><p>In many developmental events, such as limb patterning, SHH signals to neighboring cells to induce a pattern (<xref ref-type="bibr" rid="bib48">Panman and Zeller, 2003</xref>; <xref ref-type="bibr" rid="bib68">Zhulyn et al., 2014</xref>). In other developmental events, such as notochord to neural tube signaling, SHH signals produced by the notochord induce the expression of <italic>Shh</italic> in the overlaying neural tube (<xref ref-type="bibr" rid="bib24">Fuccillo et al., 2006</xref>). SHH produced by the prechordal plate may fall into the latter category, as the absence of <italic>Shh</italic> expression in <italic>Tctn2</italic><sup>-/-</sup> embryos presages reduced <italic>Shh</italic> expression and reduced expression of HH pathway transcriptional targets <italic>Gli1</italic> and <italic>Ptch1</italic> in the region of the basal forebrain sometimes referred to as the rostral diencephalon ventral midline. Thus, in the posterior midline, the notochord induces <italic>Shh</italic> expression in overlying neuroectoderm, and in the anterior midline, the prechordal plate induces <italic>Shh</italic> expression in the overlying neuroectoderm. In the failure of the prechordal plate to induce Shh expression in the overlying neurectoderm, <italic>Tctn2</italic> mutants recapitulate previous observations of <italic>Lrp2</italic> mutants which display attenuated responses to SHH (<xref ref-type="bibr" rid="bib17">Christ et al., 2012</xref>). One possible mechanism by which SHH may activate expression of <italic>Shh</italic> in the basal forebrain is via the induction of the transcription factor SIX3. SIX3 is regulated by HH signaling and required for the induction of <italic>Shh</italic> in the developing forebrain (<xref ref-type="bibr" rid="bib26">Geng et al., 2008</xref>; <xref ref-type="bibr" rid="bib36">Jeong et al., 2008</xref>). However, our observation that <italic>Six3</italic> expression is unaltered in the forebrains of <italic>Tctn2</italic> mutants diminishes support for this hypothesis.</p><p>In caudal neural tube and limb patterning, HH signals induce patterning. In hair follicles and cerebellar granule cells, HH signaling promotes proliferation. In addition to roles in patterning and proliferation, HH signals can bind to PTCH1 to inhibit apoptosis (<xref ref-type="bibr" rid="bib4">Aoto and Trainor, 2015</xref>; <xref ref-type="bibr" rid="bib8">Borycki et al., 1999</xref>; <xref ref-type="bibr" rid="bib63">Thibert et al., 2003</xref>). Our data are consistent with a role of PTCH1 in promoting apoptosis in the neuroectoderm and facial ectoderm which is inhibited by prechordal plate-produced SHH. In the absence of TCTN2, the ventral telencephalon does not produce SHH, releasing PTCH1 to promote apoptosis in the midline and resulting in midface hypoplasia. This model is consistent with previous data demonstrating that surgical ablation of the prechordal plate reduces the forebrain (<xref ref-type="bibr" rid="bib3">Aoto et al., 2009</xref>). Increased cleaved-caspase-3 and caspase-9 staining in the basal forebrain and facial ectoderm of E9.5 <italic>Tctn2</italic> mutants provides further support for apoptosis contributing to the associated midline hypoplasia.</p><p>We speculate that in tissues, such as the developing spinal cord where cilia are required for SHH expression in the floor plate, ciliary dysfunction will cause increased apoptosis. In other tissues, such as the limb bud where cilia are not required for SHH expression in the zone of proliferating activity, we predict that ciliary dysfunction will not cause increased apoptosis. Thus, ciliary dependence of SHH expression may etermine which tissues, like the craniofacial midline, increase apoptosis upon ciliary dysfunction.</p><p>To try to narrow down the tissues in which transition zone function is critical for midline facial development, we used conditional mouse genetics to delete <italic>Tctn2</italic> in different tissues that comprise the craniofacial complex. Deletion of <italic>Tctn2</italic> in the prechordal plate (via <italic>Isl1</italic><sup>Cre</sup>) or the neurectoderm (via <italic>Sox1</italic><sup>Cre</sup>) did not recapitulate the midline hypoplasia observed in <italic>Tctn2</italic><sup>-/-</sup> embryos (<xref ref-type="fig" rid="fig4s1">Figure 4âfigure supplement 1</xref>). Similarly, deletion of <italic>Tctn2</italic> in the facial ectoderm (via <italic>Tcfap2a</italic><sup>Cre</sup>) or in the forebrain and facial ectoderm (via <italic>Foxg1</italic><sup>Cre</sup>) also failed to result in midline hypoplasia (<xref ref-type="fig" rid="fig4s1">Figure 4âfigure supplement 1</xref>). These results could reflect the dispensibility of TCTN2 in these tissues for facial development, or could reflect residual TCTN2 function after <italic>Tctn2</italic> recombination. This latter possibility is supported by persistent ARL13B localization at the cilium in several tissues after conditional deletion of <italic>Tctn2</italic>. As the half-life of TCTN2 and the TCTN2 level required to sustain transition zone activity are unclear, residual TCTN2 activity may support normal ciliary signaling even after conditional gene ablation.</p><p>Surprisingly, removing one allele of <italic>Ptch1</italic> fully rescues the midface defect in both <italic>Tctn2</italic> and <italic>Cc2d2a</italic> transition zone cilia mutants. Even more surprisingly, this phenotypic rescue is not associated with restoration of either <italic>Shh</italic> expression or HH pathway activation in the basal forebrain. We propose that reducing <italic>Ptch1</italic> levels attenuates the PTCH1-mediated pro-apoptotic program normally attenuated by SHH in the basal forebrain. However, it remains possible that reducing PTCH1 levels activates GLI effectors to induce an anti-apoptotic program that does not include general HH target genes or <italic>Shh</italic>.</p><p>In summary, we have identified the primary cilia transition zone as a critical regulator of facial midline development. The transition zone component TCTN2 was critical for SHH signaling in the prechordal plate and uncovered a signaling paradigm whereby the transition zone promotes cell survival by mediating crosstalk between the prechordal plate and neurectoderm to promote HH pathway activation. These results provide insights into how primary cilia mediate cell survival to promote facial development.</p></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><table-wrap id="keyresource" position="anchor"><label>Key resources table</label><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom">Reagent type (species) or resource</th><th align="left" valign="bottom">Designation</th><th align="left" valign="bottom">Source or reference</th><th align="left" valign="bottom">Identifiers</th><th align="left" valign="bottom">Additional information</th></tr></thead><tbody><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-Arl13b (rabbit polyclonal)</td><td align="left" valign="bottom">Proteintech</td><td align="char" char="ndash" valign="bottom">17711â1-AP</td><td align="char" char="." valign="bottom">(1:1000)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-cleaved-caspase-3 (Asp175) (rabbit polyclonal)</td><td align="left" valign="bottom">Cell Signaling</td><td align="left" valign="bottom">#9664</td><td align="char" char="." valign="bottom">(1:400)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-cleaved-caspase-9 (Asp353)</td><td align="left" valign="bottom">Cell Signaling</td><td align="left" valign="bottom">#9509</td><td align="char" char="." valign="bottom">(1:100)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-phospho-histone H3 (Ser28) (rabbit polyclonal)</td><td align="left" valign="bottom">Cell Signaling</td><td align="left" valign="bottom">#9713</td><td align="char" char="." valign="bottom">(1:400)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-acetylated tubulin (mouse monoclonal)</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">T6793</td><td align="char" char="." valign="bottom">(1:1000)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-FoxA2 (rabbit monoclonal)</td><td align="left" valign="bottom">abcam</td><td align="left" valign="bottom">Ab108422</td><td align="char" char="." valign="bottom">(1:400)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-Gamma tubulin (goat polyclonal)</td><td align="left" valign="bottom">Santa Cruz Biotechnology</td><td align="left" valign="bottom">Sc-7396</td><td align="char" char="." valign="bottom">(1:200)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-GFP (chicken polyclonal)</td><td align="left" valign="bottom">Aves Labs</td><td align="left" valign="bottom">GFP-1020</td><td align="char" char="." valign="bottom">(1:1000)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-E-cadherin (rat monoclonal)</td><td align="left" valign="bottom">Invitrogen</td><td align="char" char="ndash" valign="bottom">13â1900</td><td align="char" char="." valign="bottom">(1:1000)</td></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">RNAeasy Micro Kit</td><td align="left" valign="bottom">QIAGEN</td><td align="char" char="." valign="bottom">74004</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">In Situ Cell Death Detection Kit</td><td align="left" valign="bottom">Roche</td><td align="char" char="." valign="bottom">11684795910</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">iScript cDNA synthesis kit</td><td align="left" valign="bottom">BioRad</td><td align="char" char="." valign="bottom">1708891</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>Mus musculus</italic>)</td><td align="left" valign="bottom"><italic>Tctn2<sup>tm1.1Reit</sup></italic></td><td align="left" valign="bottom">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/21565611/">21565611</ext-link></td><td align="left" valign="bottom">MGI:5292130;RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:MGI:5292219">MGI:5292219</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>Mus musculus</italic>)</td><td align="left" valign="bottom"><italic>Cc2d2a<sup>Gt(AA0274)Wtsi</sup></italic></td><td align="left" valign="bottom">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/21725307/">21725307</ext-link></td><td align="left" valign="bottom">MGI:4344514;RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:MGI:5292228">MGI:5292228</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>Mus musculus</italic>)</td><td align="left" valign="bottom"><italic>Tmem231<sup>Gt(OST335874)Lex</sup></italic></td><td align="left" valign="bottom">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/22179047/">22179047</ext-link></td><td align="left" valign="bottom">MGI:4284576;RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:MGI:5301844">MGI:5301844</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>Mus musculus</italic>)</td><td align="left" valign="bottom"><italic>Tmem67<sup>tm1Dgen</sup></italic></td><td align="left" valign="bottom">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/21725307/">21725307</ext-link></td><td align="left" valign="bottom">MGI:5292220;RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:MGI:5292226">MGI:5292226</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>Mus musculus</italic>)</td><td align="left" valign="bottom"><italic>Wnt1</italic><sup>Cre</sup>: <italic>H2az2Tg</italic><sup>(Wnt1-cre)11Rth</sup></td><td align="left" valign="bottom">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/9843687/">9843687</ext-link></td><td align="left" valign="bottom">MGI:2386570;RRIDSupplemental:IMSR_JAX:003829</td><td align="left" valign="bottom">Gift from Brian Black</td></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>Mus musculus</italic>)</td><td align="left" valign="bottom"><italic>Isl1<sup>tm1(cre)Sev</sup></italic></td><td align="left" valign="bottom">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/16556916/">16556916</ext-link></td><td align="left" valign="bottom">MGI:3623159;RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:IMSR_HAR:3351">IMSR_HAR:3351</ext-link></td><td align="left" valign="bottom">Gift from Brian Black</td></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>Mus musculus</italic>)</td><td align="left" valign="bottom"><italic>Sox1<sup>tm1(cre)Take</sup></italic></td><td align="left" valign="bottom">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/17604725/">17604725</ext-link></td><td align="left" valign="bottom">MGI:3807952;RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:IMSR_RBRC05065">IMSR_RBRC05065</ext-link></td><td align="left" valign="bottom">Gift from Jeff Bush</td></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>Mus musculus</italic>)</td><td align="left" valign="bottom"><italic>Foxg1<sup>tm1(cre)Skm</sup></italic></td><td align="left" valign="bottom">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/10837119/">10837119</ext-link></td><td align="left" valign="bottom">MGI:1932522;RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:IMSR_JAX:004337">IMSR_JAX:004337</ext-link></td><td align="left" valign="bottom">Gift from Stavros Lomvardas</td></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>Mus musculus</italic>)</td><td align="left" valign="bottom"><italic>Tg(Tcfap2a-cre)<sup>1Will</sup></italic></td><td align="left" valign="bottom">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/21087601/">21087601</ext-link></td><td align="left" valign="bottom">MGI:4887352;RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:MGI:4887452">MGI:4887452</ext-link></td><td align="left" valign="bottom">Gift from Trevor Williams</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom"><italic>Shh</italic> in situ probe</td><td align="left" valign="bottom">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/7916661/">7916661</ext-link></td><td align="left" valign="bottom"/><td align="left" valign="bottom">Gift from Andrew McMahon</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom"><italic>Gsc</italic> in situ probe</td><td align="left" valign="bottom">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/1352187/">1352187</ext-link></td><td align="left" valign="bottom"/><td align="left" valign="bottom">Gift from Edward De Robertis</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom"><italic>Ptch1</italic> in situ probe</td><td align="left" valign="bottom">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/10395791/">10395791</ext-link></td><td align="left" valign="bottom"/><td align="left" valign="bottom">Gift from Lisa Goodrich</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">RT-qPCR primers</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom"/><td align="left" valign="bottom">*See <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Genotyping primers</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom"/><td align="left" valign="bottom">*See <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref></td></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">GraphPad Prism</td><td align="left" valign="bottom">GraphPad Prism (<ext-link ext-link-type="uri" xlink:href="https://graphpad.com">https://graphpad.com</ext-link>)</td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_002798">SCR_002798</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">ImageJ</td><td align="left" valign="bottom">ImageJ (<ext-link ext-link-type="uri" xlink:href="http://imagej.nih.gov/ij/">http://imagej.nih.gov/ij/</ext-link>)</td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_003070">SCR_003070</ext-link></td><td align="left" valign="bottom"/></tr></tbody></table></table-wrap><sec id="s4-1"><title>Mouse strains</title><p>All mouse protocols were approved by the Institutional Animal Care and Use Committee (IACUC) at the University of California, San Francisco. <italic>Tctn2<sup>+/-</sup></italic> (<italic>Tctn2<sup>tm1.1Reit</sup>), Cc2d2a<sup>+/-</sup> (Cc2d2a<sup>Gt(AA0274)Wtsi</sup>), Tmem231<sup>+/-</sup> (Tmem231<sup>Gt(OST335874)Lex</sup>), and Tmem67<sup>+/-</sup> (Tmem67<sup>tm1Dgen</sup></italic>) mouse allele references can be found in the Key Resources table (<xref ref-type="bibr" rid="bib25">Garcia-Gonzalo et al., 2011</xref>). <italic>Wnt1</italic><sup>Cre</sup> (<italic>Tg(Wnt1-cre</italic>)<sup>11Rth</sup>) and <italic>Islet1</italic><sup>Cre</sup> (<italic>Isl1<sup>tm1(cre)Sev</sup></italic>) mice were obtained from Brian Black, <italic>Sox1</italic><sup>Cre</sup> (<italic>Sox1<sup>tm1(cre)Take</sup></italic>) mice were obtained from Jeff Bush, <italic>Foxg1</italic><sup>Cre</sup> (<italic>Foxg1<sup>tm1(cre)Skm</sup></italic>) mice were obtained from Stavros Lomvardas, and <italic>Tcfap2a</italic><sup>Cre</sup> (<italic>Tg(Tcfap2a-cre)<sup>1Will</sup></italic>) mice were obtained from Trevor Williams. The <italic>Ptch1<sup>tm1Mps</sup></italic> allele was used in this study as a null allele. The <italic>Tctn2</italic> conditional allele (<italic>Tctn2</italic><sup>lox</sup> or <italic>Tctn2<sup>tm1cReit</sup></italic>) was derived from the <italic>Tctn2<sup>tm1aReit</sup></italic> allele from which the validated <italic>Tctn2<sup>tm1.1Reit</sup></italic> null allele was previously derived (<xref ref-type="bibr" rid="bib25">Garcia-Gonzalo et al., 2011</xref>; <xref ref-type="bibr" rid="bib52">Sang et al., 2011</xref>). More specifically, we removed the puromycin resistance cassette of <italic>Tctn2<sup>tm1aReit</sup></italic> by Cre-mediated recombination, leaving two loxP sites flanking the first three <italic>Tctn2</italic> exons to generate <italic>Tctn2</italic><sup>fl</sup>. All mice were maintained on a C57BL/6J background. For timed matings, noon on the day a copulation plug was detected was considered to be 0.5 days postcoitus. Genotyping primers for all mouse strains used in this study can be found in <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>.</p></sec><sec id="s4-2"><title>Immunofluorescence</title><p>The antibodies used in this study were rabbit Î±-ARL13B (1:1000, Proteintech 17711â1-AP), rabbit Î±-cleaved-caspase-3 (Asp175) (1:400, Cell Signaling #9664), rabbit Î±-cleaved-caspase-9 (Asp353) (1:100, Cell Signaling #9509), rabbit Î±-phospho-histone H3 (Ser28) (1:400, Cell Signaling #9713), chicken anti-GFP (1:1000, Aves labs GFP-1020), goat gamma-tubulin (1:200, Santa Cruz sc7396), mouse acetylated-tubulin (1:1000, Sigma T6793), rat E-cadherin (1:1000, Invitrogen 13â1900), and rabbit FoxA2 (1:400 abcam ab108422). The In Situ Cell Death Detection Kit, Fluorescein (Roche) was used for TUNEL cell death assay. For immunofluorescence antibody staining of frozen tissue sections, embryos were fixed overnight in 4% PFA/PBS, washed in PBS and cryopreserved via overnight incubation in 30% sucrose/PBS. Embryos were embedded in OCT and frozen at â80Â°C. Frozen OCT blocks were cut into 10 Î¼M sections. For immunostaining, frozen sections were washed 3 Ã 5â in PBST (0.1%Tween-20/PBS) followed by blocking for 2hr in blocking solution (5% donkey serum in PBS + 0.3% Triton X-100 +0.2% Na-azide). Slides were incubated overnight in primary antibody diluted in blocking solution at 4 degrees. The following day, slides were washed 3 Ã 10â in PBST, stained with appropriate AlexaFluor 488, 568, or 647 conjugated secondary antibodies (Life Technologies) at 1:1000 and Hoecsht or DAPI nuclear stain in blocking buffer for 1 hr, rinsed 3 Ã 10â with PBST and mounted using Fluoromount-G (Southern Biotech). All steps performed at room temperature unless otherwise noted. *Note: For gamma-tubulin antibody staining, antigen retrieval by incubating with 1%SDS/PBST for 5 min prior to blocking and primary antibody incubation is required for good staining. Stained samples were imaged on a Leica SP-5 confocal microscope. Images were processed using FIJI (ImageJ).</p></sec><sec id="s4-3"><title>In situ hybridization</title><p>WM-ISH was performed as previously described (<xref ref-type="bibr" rid="bib28">Harrelson et al., 2012</xref>). DIG-labeled riboprobes were made using plasmids from the following sources: <italic>Shh</italic> (<xref ref-type="bibr" rid="bib23">Echelard et al., 1993</xref>), <italic>Gsc</italic> (<xref ref-type="bibr" rid="bib7">Blum et al., 1992</xref>), <italic>Ptch1</italic> (<xref ref-type="bibr" rid="bib27">Goodrich et al., 1999</xref>), <italic>Foxa2</italic> (<xref ref-type="bibr" rid="bib9">Brennan et al., 2001</xref>), <italic>Gli1</italic> (EST W65013).</p></sec><sec id="s4-4"><title>RT-qPCR</title><p>For gene expression studies, RNA was extracted from E8.5/E9.5 embryo heads using an RNAeasy Micro Kit (QIAGEN), and cDNA synthesis was performed using the iScript cDNA synthesis kit (BioRad). RT-qPCR was performed using EXPRESS Sybr GreenER 2Ã master mix with ROX (Invitrogen) and primers homologous to <italic>Shh, Ptch1,</italic> or <italic>Gli1</italic> on an ABI 7900HT RT-PCR machine. Expression levels were normalized to the geometric mean of three control genes (<italic>Actb, Hprt</italic> and <italic>Ubc</italic>), average normalized Ct values for control and experimental groups determined, and relative expression levels determined by ÎÎCt. The RT-qPCR of each RNA sample was performed in quadruplicate with a minimum of N = 3 biological replicates (biologically distinct samples) per genotype. All primers used for RT-qPCR experiments can be found in <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>.</p></sec><sec id="s4-5"><title>Embryo processing for midface imaging</title><p>Embryos were harvested in ice-cold PBS, staged by counting somite number, and fixed o/n at 4 degrees in 4%PFA/PBS. Embryo heads were removed and stained in 0.01% ethidium bromide in PBS at room temperature for 15 min. Embryos were positioned using glass beads in PBS and imaged on a Leica MZ16 F fluorescence stereomicroscope.</p></sec><sec id="s4-6"><title>Image Quantification</title><p>For 2D midface width quantification, the infranasal distance was measured using FIJI software by drawing a line between the center of each nasal pit. For quantification of cell death and proliferation assays, a minimum of two sections per embryo were quantified over three biological replicates (biologically distinct samples). Staining with epithelial marker E-cadherin was used for quantification of facial ectoderm while nuclear morphology was used to separate mesenchyme, hindbrain, and forebrain tissue compartments. For quantification, threshold was first set for each image followed by binary watershed separation to obtain accurate nuclei counts. The percentage of TUNEL<sup>+</sup> or pHH3<sup>+</sup> nuclei were compared between <italic>Tctn2</italic> mutant and control samples.</p></sec></sec></body><back><sec id="s5" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn><fn fn-type="COI-statement" id="conf2"><p>Reviewing editor, eLife</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Data curation, Formal analysis, Investigation, Methodology, Validation, Visualization, Writing â original draft</p></fn><fn fn-type="con" id="con2"><p>Conceptualization, Funding acquisition, Project administration, Writing â review and editing</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>This study was performed in strict accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health. All mouse protocols were approved by the Institutional Animal Care and Use Committee (IACUC) of the University of California, San Francisco (protocol AN178683).</p></fn></fn-group></sec><sec id="s6" sec-type="supplementary-material"><title>Additional files</title><supplementary-material id="supp1"><label>Supplementary file 1.</label><caption><title>Primer sets used for genotyping and quantitative real-time polymerase chain reaction (RT-qPCR).</title><p>File contains all sequencing primer pairs used for genotyping of all mouse strains used in this study. In addition, file contains primer sets used for RT-qPCR experiments. Inquiries regarding primers should be sent to Jeremy Reiter.</p></caption><media mime-subtype="pdf" mimetype="application" xlink:href="elife-68558-supp1-v2.pdf"/></supplementary-material><supplementary-material id="transrepform"><label>Transparent reporting form</label><media mime-subtype="docx" mimetype="application" xlink:href="elife-68558-transrepform1-v2.docx"/></supplementary-material></sec><sec id="s7" sec-type="data-availability"><title>Data availability</title><p>All data generated or analysed during this study are included in the manuscript and supporting files.</p></sec><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ahlgren</surname><given-names>SC</given-names></name><name><surname>Bronner-Fraser</surname><given-names>M</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>Inhibition of sonic hedgehog signaling in vivo results in craniofacial neural crest cell death</article-title><source>Current Biology</source><volume>9</volume><fpage>1304</fpage><lpage>1314</lpage><pub-id pub-id-type="doi">10.1016/S0960-9822(00)80052-4</pub-id><pub-id pub-id-type="pmid">10574760</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anderson</surname><given-names>C</given-names></name><name><surname>Stern</surname><given-names>CD</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Organizers in Development</article-title><source>Current Topics in Developmental Biology</source><volume>117</volume><fpage>435</fpage><lpage>454</lpage><pub-id pub-id-type="doi">10.1016/bs.ctdb.2015.11.023</pub-id><pub-id pub-id-type="pmid">26969994</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aoto</surname><given-names>K</given-names></name><name><surname>Shikata</surname><given-names>Y</given-names></name><name><surname>Imai</surname><given-names>H</given-names></name><name><surname>Matsumaru</surname><given-names>D</given-names></name><name><surname>Tokunaga</surname><given-names>T</given-names></name><name><surname>Shioda</surname><given-names>S</given-names></name><name><surname>Yamada</surname><given-names>G</given-names></name><name><surname>Motoyama</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Mouse Shh is required for prechordal plate maintenance during brain and craniofacial morphogenesis</article-title><source>Developmental Biology</source><volume>327</volume><fpage>106</fpage><lpage>120</lpage><pub-id pub-id-type="doi">10.1016/j.ydbio.2008.11.022</pub-id><pub-id pub-id-type="pmid">19103193</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aoto</surname><given-names>K</given-names></name><name><surname>Trainor</surname><given-names>PA</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Co-ordinated brain and craniofacial development depend upon Patched1/XIAP regulation of cell survival</article-title><source>Human Molecular Genetics</source><volume>24</volume><fpage>698</fpage><lpage>713</lpage><pub-id pub-id-type="doi">10.1093/hmg/ddu489</pub-id><pub-id pub-id-type="pmid">25292199</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baker</surname><given-names>K</given-names></name><name><surname>Beales</surname><given-names>PL</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Making sense of cilia in disease: The human ciliopathies</article-title><source>American Journal of Medical Genetics Part C</source><volume>151C</volume><fpage>281</fpage><lpage>295</lpage><pub-id pub-id-type="doi">10.1002/ajmg.c.30231</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Belo</surname><given-names>JA</given-names></name><name><surname>Leyns</surname><given-names>L</given-names></name><name><surname>Yamada</surname><given-names>G</given-names></name><name><surname>De Robertis</surname><given-names>EM</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title>The prechordal midline of the chondrocranium is defective in Goosecoid-1 mouse mutants</article-title><source>Mechanisms of Development</source><volume>72</volume><fpage>15</fpage><lpage>25</lpage><pub-id pub-id-type="doi">10.1016/s0925-4773(97)00204-9</pub-id><pub-id pub-id-type="pmid">9533949</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blum</surname><given-names>M</given-names></name><name><surname>Gaunt</surname><given-names>SJ</given-names></name><name><surname>Cho</surname><given-names>KW</given-names></name><name><surname>Steinbeisser</surname><given-names>H</given-names></name><name><surname>Blumberg</surname><given-names>B</given-names></name><name><surname>Bittner</surname><given-names>D</given-names></name><name><surname>De Robertis</surname><given-names>EM</given-names></name></person-group><year iso-8601-date="1992">1992</year><article-title>Gastrulation in the mouse: the role of the homeobox gene goosecoid</article-title><source>Cell</source><volume>69</volume><fpage>1097</fpage><lpage>1106</lpage><pub-id pub-id-type="doi">10.1016/0092-8674(92)90632-M</pub-id><pub-id pub-id-type="pmid">1352187</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Borycki</surname><given-names>AG</given-names></name><name><surname>Brunk</surname><given-names>B</given-names></name><name><surname>Tajbakhsh</surname><given-names>S</given-names></name><name><surname>Buckingham</surname><given-names>M</given-names></name><name><surname>Chiang</surname><given-names>C</given-names></name><name><surname>Emerson</surname><given-names>CP</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>Sonic hedgehog controls epaxial muscle determination through Myf5 activation</article-title><source>Development</source><volume>126</volume><fpage>4053</fpage><lpage>4063</lpage><pub-id pub-id-type="pmid">10457014</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brennan</surname><given-names>J</given-names></name><name><surname>Lu</surname><given-names>CC</given-names></name><name><surname>Norris</surname><given-names>DP</given-names></name><name><surname>Rodriguez</surname><given-names>TA</given-names></name><name><surname>Beddington</surname><given-names>RS</given-names></name><name><surname>Robertson</surname><given-names>EJ</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Nodal signalling in the epiblast patterns the early mouse embryo</article-title><source>Nature</source><volume>411</volume><fpage>965</fpage><lpage>969</lpage><pub-id pub-id-type="doi">10.1038/35082103</pub-id><pub-id pub-id-type="pmid">11418863</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brugmann</surname><given-names>SA</given-names></name><name><surname>Allen</surname><given-names>NC</given-names></name><name><surname>James</surname><given-names>AW</given-names></name><name><surname>Mekonnen</surname><given-names>Z</given-names></name><name><surname>Madan</surname><given-names>E</given-names></name><name><surname>Helms</surname><given-names>JA</given-names></name></person-group><year iso-8601-date="2010">2010a</year><article-title>A primary cilia-dependent etiology for midline facial disorders</article-title><source>Human Molecular Genetics</source><volume>19</volume><fpage>1577</fpage><lpage>1592</lpage><pub-id pub-id-type="doi">10.1093/hmg/ddq030</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brugmann</surname><given-names>SA</given-names></name><name><surname>Cordero</surname><given-names>DR</given-names></name><name><surname>Helms</surname><given-names>JA</given-names></name></person-group><year iso-8601-date="2010">2010b</year><article-title>Craniofacial ciliopathies: A new classification for craniofacial disorders</article-title><source>American Journal of Medical Genetics Part A</source><volume>152A</volume><fpage>2995</fpage><lpage>3006</lpage><pub-id pub-id-type="doi">10.1002/ajmg.a.33727</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Camus</surname><given-names>A</given-names></name><name><surname>Davidson</surname><given-names>BP</given-names></name><name><surname>Billiards</surname><given-names>S</given-names></name><name><surname>Khoo</surname><given-names>P</given-names></name><name><surname>Rivera-PÃ©rez</surname><given-names>JA</given-names></name><name><surname>Wakamiya</surname><given-names>M</given-names></name><name><surname>Behringer</surname><given-names>RR</given-names></name><name><surname>Tam</surname><given-names>PP</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>The morphogenetic role of midline mesendoderm and ectoderm in the development of the forebrain and the midbrain of the mouse embryo</article-title><source>Development</source><volume>127</volume><fpage>1799</fpage><lpage>1813</lpage><pub-id pub-id-type="doi">10.1242/dev.127.9.1799</pub-id><pub-id pub-id-type="pmid">10751169</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chang</surname><given-names>C-F</given-names></name><name><surname>Schock</surname><given-names>EN</given-names></name><name><surname>OâHare</surname><given-names>EA</given-names></name><name><surname>Dodgson</surname><given-names>J</given-names></name><name><surname>Cheng</surname><given-names>HH</given-names></name><name><surname>Muir</surname><given-names>WM</given-names></name><name><surname>Edelmann</surname><given-names>RE</given-names></name><name><surname>Delany</surname><given-names>ME</given-names></name><name><surname>Brugmann</surname><given-names>SA</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>The cellular and molecular etiology of the craniofacial defects in the avian ciliopathic mutant talpid2</article-title><source>Development</source><volume>141</volume><fpage>3003</fpage><lpage>3012</lpage><pub-id pub-id-type="doi">10.1242/dev.105924</pub-id><pub-id pub-id-type="pmid">25053433</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chang</surname><given-names>C-F</given-names></name><name><surname>Chang</surname><given-names>Y-T</given-names></name><name><surname>Millington</surname><given-names>G</given-names></name><name><surname>Brugmann</surname><given-names>SA</given-names></name><name><surname>Wilkie</surname><given-names>AOM</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Craniofacial Ciliopathies Reveal Specific Requirements for GLI Proteins during Development of the Facial Midline</article-title><source>PLOS Genetics</source><volume>12</volume><elocation-id>e1006351</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pgen.1006351</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chiang</surname><given-names>C</given-names></name><name><surname>Litingtung</surname><given-names>Y</given-names></name><name><surname>Lee</surname><given-names>E</given-names></name><name><surname>Young</surname><given-names>KE</given-names></name><name><surname>Corden</surname><given-names>JL</given-names></name><name><surname>Westphal</surname><given-names>H</given-names></name><name><surname>Beachy</surname><given-names>PA</given-names></name></person-group><year iso-8601-date="1996">1996</year><article-title>Cyclopia and defective axial patterning in mice lacking Sonic hedgehog gene function</article-title><source>Nature</source><volume>383</volume><fpage>407</fpage><lpage>413</lpage><pub-id pub-id-type="doi">10.1038/383407a0</pub-id><pub-id pub-id-type="pmid">8837770</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chih</surname><given-names>B</given-names></name><name><surname>Liu</surname><given-names>P</given-names></name><name><surname>Chinn</surname><given-names>Y</given-names></name><name><surname>Chalouni</surname><given-names>C</given-names></name><name><surname>Komuves</surname><given-names>LG</given-names></name><name><surname>Hass</surname><given-names>PE</given-names></name><name><surname>Sandoval</surname><given-names>W</given-names></name><name><surname>Peterson</surname><given-names>AS</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>A ciliopathy complex at the transition zone protects the cilia as a privileged membrane domain</article-title><source>Nature Cell Biology</source><volume>14</volume><fpage>61</fpage><lpage>72</lpage><pub-id pub-id-type="doi">10.1038/ncb2410</pub-id><pub-id pub-id-type="pmid">22179047</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Christ</surname><given-names>A</given-names></name><name><surname>Christa</surname><given-names>A</given-names></name><name><surname>Kur</surname><given-names>E</given-names></name><name><surname>Lioubinski</surname><given-names>O</given-names></name><name><surname>Bachmann</surname><given-names>S</given-names></name><name><surname>Willnow</surname><given-names>TE</given-names></name><name><surname>Hammes</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>LRP2 is an auxiliary SHH receptor required to condition the forebrain ventral midline for inductive signals</article-title><source>Developmental Cell</source><volume>22</volume><fpage>268</fpage><lpage>278</lpage><pub-id pub-id-type="doi">10.1016/j.devcel.2011.11.023</pub-id><pub-id pub-id-type="pmid">22340494</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cohen</surname><given-names>MM</given-names></name><name><surname>Shiota</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Teratogenesis of holoprosencephaly</article-title><source>American Journal of Medical Genetics</source><volume>109</volume><fpage>1</fpage><lpage>15</lpage><pub-id pub-id-type="doi">10.1002/ajmg.10258</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Corbit</surname><given-names>KC</given-names></name><name><surname>Aanstad</surname><given-names>P</given-names></name><name><surname>Singla</surname><given-names>V</given-names></name><name><surname>Norman</surname><given-names>AR</given-names></name><name><surname>Stainier</surname><given-names>DYR</given-names></name><name><surname>Reiter</surname><given-names>JF</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Vertebrate Smoothened functions at the primary cilium</article-title><source>Nature</source><volume>437</volume><fpage>1018</fpage><lpage>1021</lpage><pub-id pub-id-type="doi">10.1038/nature04117</pub-id><pub-id pub-id-type="pmid">16136078</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dale</surname><given-names>JK</given-names></name><name><surname>Vesque</surname><given-names>C</given-names></name><name><surname>Lints</surname><given-names>TJ</given-names></name><name><surname>Sampath</surname><given-names>TK</given-names></name><name><surname>Furley</surname><given-names>A</given-names></name><name><surname>Dodd</surname><given-names>J</given-names></name><name><surname>Placzek</surname><given-names>M</given-names></name></person-group><year iso-8601-date="1997">1997</year><article-title>Cooperation of BMP7 and SHH in the induction of forebrain ventral midline cells by prechordal mesoderm</article-title><source>Cell</source><volume>90</volume><fpage>257</fpage><lpage>269</lpage><pub-id pub-id-type="doi">10.1016/s0092-8674(00)80334-7</pub-id><pub-id pub-id-type="pmid">9244300</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Diez-Roux</surname><given-names>G</given-names></name><name><surname>Banfi</surname><given-names>S</given-names></name><name><surname>Sultan</surname><given-names>M</given-names></name><name><surname>Geffers</surname><given-names>L</given-names></name><name><surname>Anand</surname><given-names>S</given-names></name><name><surname>Rozado</surname><given-names>D</given-names></name><name><surname>Magen</surname><given-names>A</given-names></name><name><surname>Canidio</surname><given-names>E</given-names></name><name><surname>Pagani</surname><given-names>M</given-names></name><name><surname>Peluso</surname><given-names>I</given-names></name><name><surname>Lin-Marq</surname><given-names>N</given-names></name><name><surname>Koch</surname><given-names>M</given-names></name><name><surname>Bilio</surname><given-names>M</given-names></name><name><surname>Cantiello</surname><given-names>I</given-names></name><name><surname>Verde</surname><given-names>R</given-names></name><name><surname>De Masi</surname><given-names>C</given-names></name><name><surname>Bianchi</surname><given-names>SA</given-names></name><name><surname>Cicchini</surname><given-names>J</given-names></name><name><surname>Perroud</surname><given-names>E</given-names></name><name><surname>Mehmeti</surname><given-names>S</given-names></name><name><surname>Dagand</surname><given-names>E</given-names></name><name><surname>Schrinner</surname><given-names>S</given-names></name><name><surname>NÃ¼rnberger</surname><given-names>A</given-names></name><name><surname>Schmidt</surname><given-names>K</given-names></name><name><surname>Metz</surname><given-names>K</given-names></name><name><surname>Zwingmann</surname><given-names>C</given-names></name><name><surname>Brieske</surname><given-names>N</given-names></name><name><surname>Springer</surname><given-names>C</given-names></name><name><surname>Hernandez</surname><given-names>AM</given-names></name><name><surname>Herzog</surname><given-names>S</given-names></name><name><surname>Grabbe</surname><given-names>F</given-names></name><name><surname>Sieverding</surname><given-names>C</given-names></name><name><surname>Fischer</surname><given-names>B</given-names></name><name><surname>Schrader</surname><given-names>K</given-names></name><name><surname>Brockmeyer</surname><given-names>M</given-names></name><name><surname>Dettmer</surname><given-names>S</given-names></name><name><surname>Helbig</surname><given-names>C</given-names></name><name><surname>Alunni</surname><given-names>V</given-names></name><name><surname>Battaini</surname><given-names>M-A</given-names></name><name><surname>Mura</surname><given-names>C</given-names></name><name><surname>Henrichsen</surname><given-names>CN</given-names></name><name><surname>Garcia-Lopez</surname><given-names>R</given-names></name><name><surname>Echevarria</surname><given-names>D</given-names></name><name><surname>Puelles</surname><given-names>E</given-names></name><name><surname>Garcia-Calero</surname><given-names>E</given-names></name><name><surname>Kruse</surname><given-names>S</given-names></name><name><surname>Uhr</surname><given-names>M</given-names></name><name><surname>Kauck</surname><given-names>C</given-names></name><name><surname>Feng</surname><given-names>G</given-names></name><name><surname>Milyaev</surname><given-names>N</given-names></name><name><surname>Ong</surname><given-names>CK</given-names></name><name><surname>Kumar</surname><given-names>L</given-names></name><name><surname>Lam</surname><given-names>M</given-names></name><name><surname>Semple</surname><given-names>CA</given-names></name><name><surname>Gyenesei</surname><given-names>A</given-names></name><name><surname>Mundlos</surname><given-names>S</given-names></name><name><surname>Radelof</surname><given-names>U</given-names></name><name><surname>Lehrach</surname><given-names>H</given-names></name><name><surname>Sarmientos</surname><given-names>P</given-names></name><name><surname>Reymond</surname><given-names>A</given-names></name><name><surname>Davidson</surname><given-names>DR</given-names></name><name><surname>DollÃ©</surname><given-names>P</given-names></name><name><surname>Antonarakis</surname><given-names>SE</given-names></name><name><surname>Yaspo</surname><given-names>M-L</given-names></name><name><surname>Martinez</surname><given-names>S</given-names></name><name><surname>Baldock</surname><given-names>RA</given-names></name><name><surname>Eichele</surname><given-names>G</given-names></name><name><surname>Ballabio</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>A high-resolution anatomical atlas of the transcriptome in the mouse embryo</article-title><source>PLOS Biology</source><volume>9</volume><elocation-id>e1000582</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pbio.1000582</pub-id><pub-id pub-id-type="pmid">21267068</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dowdle</surname><given-names>WE</given-names></name><name><surname>Robinson</surname><given-names>JF</given-names></name><name><surname>Kneist</surname><given-names>A</given-names></name><name><surname>Sirerol-Piquer</surname><given-names>MS</given-names></name><name><surname>Frints</surname><given-names>SGM</given-names></name><name><surname>Corbit</surname><given-names>KC</given-names></name><name><surname>Zaghloul</surname><given-names>NA</given-names></name><name><surname>Zaghloul</surname><given-names>NA</given-names></name><name><surname>van Lijnschoten</surname><given-names>G</given-names></name><name><surname>Mulders</surname><given-names>L</given-names></name><name><surname>Verver</surname><given-names>DE</given-names></name><name><surname>Zerres</surname><given-names>K</given-names></name><name><surname>Reed</surname><given-names>RR</given-names></name><name><surname>AttiÃ©-Bitach</surname><given-names>T</given-names></name><name><surname>Johnson</surname><given-names>CA</given-names></name><name><surname>GarcÃ­a-Verdugo</surname><given-names>JM</given-names></name><name><surname>Katsanis</surname><given-names>N</given-names></name><name><surname>Bergmann</surname><given-names>C</given-names></name><name><surname>Reiter</surname><given-names>JF</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Disruption of a ciliary B9 protein complex causes Meckel syndrome</article-title><source>American Journal of Human Genetics</source><volume>89</volume><fpage>94</fpage><lpage>110</lpage><pub-id pub-id-type="doi">10.1016/j.ajhg.2011.06.003</pub-id><pub-id pub-id-type="pmid">21763481</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Echelard</surname><given-names>Y</given-names></name><name><surname>Epstein</surname><given-names>DJ</given-names></name><name><surname>St-Jacques</surname><given-names>B</given-names></name><name><surname>Shen</surname><given-names>L</given-names></name><name><surname>Mohler</surname><given-names>J</given-names></name><name><surname>McMahon</surname><given-names>JA</given-names></name><name><surname>McMahon</surname><given-names>AP</given-names></name></person-group><year iso-8601-date="1993">1993</year><article-title>Sonic hedgehog, a member of a family of putative signaling molecules, is implicated in the regulation of CNS polarity</article-title><source>Cell</source><volume>75</volume><fpage>1417</fpage><lpage>1430</lpage><pub-id pub-id-type="doi">10.1016/0092-8674(93)90627-3</pub-id><pub-id pub-id-type="pmid">7916661</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fuccillo</surname><given-names>M</given-names></name><name><surname>Joyner</surname><given-names>AL</given-names></name><name><surname>Fishell</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Morphogen to mitogen: the multiple roles of hedgehog signalling in vertebrate neural development</article-title><source>Nature Reviews. Neuroscience</source><volume>7</volume><fpage>772</fpage><lpage>783</lpage><pub-id pub-id-type="doi">10.1038/nrn1990</pub-id><pub-id pub-id-type="pmid">16988653</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garcia-Gonzalo</surname><given-names>FR</given-names></name><name><surname>Corbit</surname><given-names>KC</given-names></name><name><surname>Sirerol-Piquer</surname><given-names>MS</given-names></name><name><surname>Ramaswami</surname><given-names>G</given-names></name><name><surname>Otto</surname><given-names>EA</given-names></name><name><surname>Noriega</surname><given-names>TR</given-names></name><name><surname>Seol</surname><given-names>AD</given-names></name><name><surname>Robinson</surname><given-names>JF</given-names></name><name><surname>Bennett</surname><given-names>CL</given-names></name><name><surname>Josifova</surname><given-names>DJ</given-names></name><name><surname>GarcÃ­a-Verdugo</surname><given-names>JM</given-names></name><name><surname>Katsanis</surname><given-names>N</given-names></name><name><surname>Hildebrandt</surname><given-names>F</given-names></name><name><surname>Reiter</surname><given-names>JF</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>A transition zone complex regulates mammalian ciliogenesis and ciliary membrane composition</article-title><source>Nature Genetics</source><volume>43</volume><fpage>776</fpage><lpage>784</lpage><pub-id pub-id-type="doi">10.1038/ng.891</pub-id><pub-id pub-id-type="pmid">21725307</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Geng</surname><given-names>X</given-names></name><name><surname>Speirs</surname><given-names>C</given-names></name><name><surname>Lagutin</surname><given-names>O</given-names></name><name><surname>Inbal</surname><given-names>A</given-names></name><name><surname>Liu</surname><given-names>W</given-names></name><name><surname>Solnica-Krezel</surname><given-names>L</given-names></name><name><surname>Jeong</surname><given-names>Y</given-names></name><name><surname>Epstein</surname><given-names>DJ</given-names></name><name><surname>Oliver</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Haploinsufficiency of Six3 fails to activate Sonic hedgehog expression in the ventral forebrain and causes holoprosencephaly</article-title><source>Developmental Cell</source><volume>15</volume><fpage>236</fpage><lpage>247</lpage><pub-id pub-id-type="doi">10.1016/j.devcel.2008.07.003</pub-id><pub-id pub-id-type="pmid">18694563</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goodrich</surname><given-names>LV</given-names></name><name><surname>Jung</surname><given-names>D</given-names></name><name><surname>Higgins</surname><given-names>KM</given-names></name><name><surname>Scott</surname><given-names>MP</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>Overexpression of ptc1 Inhibits Induction of Shh Target Genes and Prevents Normal Patterning in the Neural Tube</article-title><source>Developmental Biology</source><volume>211</volume><fpage>323</fpage><lpage>334</lpage><pub-id pub-id-type="doi">10.1006/dbio.1999.9311</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harrelson</surname><given-names>Z</given-names></name><name><surname>Kaestner</surname><given-names>KH</given-names></name><name><surname>Evans</surname><given-names>SM</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Foxa2 mediates critical functions of prechordal plate in patterning and morphogenesis and is cell autonomously required for early ventral endoderm morphogenesis</article-title><source>Biology Open</source><volume>1</volume><fpage>173</fpage><lpage>181</lpage><pub-id pub-id-type="doi">10.1242/bio.2012040</pub-id><pub-id pub-id-type="pmid">23213408</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Herrmann</surname><given-names>BG</given-names></name></person-group><year iso-8601-date="1991">1991</year><article-title>Expression pattern of the Brachyury gene in whole-mount TWis/TWis mutant embryos</article-title><source>Development</source><volume>113</volume><fpage>913</fpage><lpage>917</lpage><pub-id pub-id-type="doi">10.1242/dev.113.3.913</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hildebrandt</surname><given-names>F</given-names></name><name><surname>Benzing</surname><given-names>T</given-names></name><name><surname>Katsanis</surname><given-names>N</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Ciliopathies</article-title><source>The New England Journal of Medicine</source><volume>364</volume><fpage>1533</fpage><lpage>1543</lpage><pub-id pub-id-type="doi">10.1056/NEJMra1010172</pub-id><pub-id pub-id-type="pmid">21506742</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hu</surname><given-names>D</given-names></name><name><surname>Helms</surname><given-names>JA</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>The role of sonic hedgehog in normal and abnormal craniofacial morphogenesis</article-title><source>Development</source><volume>126</volume><fpage>4873</fpage><lpage>4884</lpage><pub-id pub-id-type="pmid">10518503</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hu</surname><given-names>D</given-names></name><name><surname>Marcucio</surname><given-names>RS</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>A SHH-responsive signaling center in the forebrain regulates craniofacial morphogenesis via the facial ectoderm</article-title><source>Development</source><volume>136</volume><fpage>107</fpage><lpage>116</lpage><pub-id pub-id-type="doi">10.1242/dev.026583</pub-id><pub-id pub-id-type="pmid">19036802</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hu</surname><given-names>D</given-names></name><name><surname>Young</surname><given-names>NM</given-names></name><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Xu</surname><given-names>Y</given-names></name><name><surname>HallgrÃ­msson</surname><given-names>B</given-names></name><name><surname>Marcucio</surname><given-names>RS</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>A dynamic Shh expression pattern, regulated by SHH and BMP signaling, coordinates fusion of primordia in the amniote face</article-title><source>Development</source><volume>142</volume><fpage>567</fpage><lpage>574</lpage><pub-id pub-id-type="doi">10.1242/dev.114835</pub-id><pub-id pub-id-type="pmid">25605783</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huppke</surname><given-names>P</given-names></name><name><surname>Wegener</surname><given-names>E</given-names></name><name><surname>BÃ¶hrer-Rabel</surname><given-names>H</given-names></name><name><surname>Bolz</surname><given-names>HJ</given-names></name><name><surname>Zoll</surname><given-names>B</given-names></name><name><surname>GÃ¤rtner</surname><given-names>J</given-names></name><name><surname>Bergmann</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Tectonic gene mutations in patients with Joubert syndrome</article-title><source>European Journal of Human Genetics</source><volume>23</volume><fpage>616</fpage><lpage>620</lpage><pub-id pub-id-type="doi">10.1038/ejhg.2014.160</pub-id><pub-id pub-id-type="pmid">25118024</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>IzpisÃºa-Belmonte</surname><given-names>JC</given-names></name><name><surname>De Robertis</surname><given-names>EM</given-names></name><name><surname>Storey</surname><given-names>KG</given-names></name><name><surname>Stern</surname><given-names>CD</given-names></name></person-group><year iso-8601-date="1993">1993</year><article-title>The homeobox gene goosecoid and the origin of organizer cells in the early chick blastoderm</article-title><source>Cell</source><volume>74</volume><fpage>645</fpage><lpage>659</lpage><pub-id pub-id-type="doi">10.1016/0092-8674(93)90512-O</pub-id><pub-id pub-id-type="pmid">7916659</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jeong</surname><given-names>Y</given-names></name><name><surname>Leskow</surname><given-names>FC</given-names></name><name><surname>El-Jaick</surname><given-names>K</given-names></name><name><surname>Roessler</surname><given-names>E</given-names></name><name><surname>Muenke</surname><given-names>M</given-names></name><name><surname>Yocum</surname><given-names>A</given-names></name><name><surname>Dubourg</surname><given-names>C</given-names></name><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Geng</surname><given-names>X</given-names></name><name><surname>Oliver</surname><given-names>G</given-names></name><name><surname>Epstein</surname><given-names>DJ</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Regulation of a remote Shh forebrain enhancer by the Six3 homeoprotein</article-title><source>Nature Genetics</source><volume>40</volume><fpage>1348</fpage><lpage>1353</lpage><pub-id pub-id-type="doi">10.1038/ng.230</pub-id><pub-id pub-id-type="pmid">18836447</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jin</surname><given-names>O</given-names></name><name><surname>Harpal</surname><given-names>K</given-names></name><name><surname>Ang</surname><given-names>SL</given-names></name><name><surname>Rossant</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Otx2 and HNF3beta genetically interact in anterior patterning</article-title><source>The International Journal of Developmental Biology</source><volume>45</volume><fpage>357</fpage><lpage>365</lpage><pub-id pub-id-type="pmid">11291866</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kiecker</surname><given-names>C</given-names></name><name><surname>Niehrs</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>The role of prechordal mesendoderm in neural patterning</article-title><source>Current Opinion in Neurobiology</source><volume>11</volume><fpage>27</fpage><lpage>33</lpage><pub-id pub-id-type="doi">10.1016/s0959-4388(00)00170-7</pub-id><pub-id pub-id-type="pmid">11179869</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Litingtung</surname><given-names>Y</given-names></name><name><surname>Chiang</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Specification of ventral neuron types is mediated by an antagonistic interaction between Shh and Gli3</article-title><source>Nature Neuroscience</source><volume>3</volume><fpage>979</fpage><lpage>985</lpage><pub-id pub-id-type="doi">10.1038/79916</pub-id><pub-id pub-id-type="pmid">11017169</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>B</given-names></name><name><surname>Chen</surname><given-names>S</given-names></name><name><surname>Johnson</surname><given-names>C</given-names></name><name><surname>Helms</surname><given-names>JA</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Reproductive Toxicology</article-title><source>Reproductive Toxicology</source><volume>48</volume><fpage>88</fpage><lpage>97</lpage><pub-id pub-id-type="doi">10.1016/j.reprotox.2014.05.009</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>MacRae</surname><given-names>DW</given-names></name><name><surname>Howard</surname><given-names>RO</given-names></name><name><surname>Albert</surname><given-names>DM</given-names></name><name><surname>Hsia</surname><given-names>YE</given-names></name></person-group><year iso-8601-date="1972">1972</year><article-title>Ocular manifestations of the Meckel syndrome</article-title><source>Archives of Ophthalmology</source><volume>88</volume><fpage>106</fpage><lpage>113</lpage><pub-id pub-id-type="doi">10.1001/archopht.1972.01000030108028</pub-id><pub-id pub-id-type="pmid">4626079</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Magdaleno</surname><given-names>S</given-names></name><name><surname>Jensen</surname><given-names>P</given-names></name><name><surname>Brumwell</surname><given-names>CL</given-names></name><name><surname>Seal</surname><given-names>A</given-names></name><name><surname>Lehman</surname><given-names>K</given-names></name><name><surname>Asbury</surname><given-names>A</given-names></name><name><surname>Cheung</surname><given-names>T</given-names></name><name><surname>Cornelius</surname><given-names>T</given-names></name><name><surname>Batten</surname><given-names>DM</given-names></name><name><surname>Eden</surname><given-names>C</given-names></name><name><surname>Norland</surname><given-names>SM</given-names></name><name><surname>Rice</surname><given-names>DS</given-names></name><name><surname>Dosooye</surname><given-names>N</given-names></name><name><surname>Shakya</surname><given-names>S</given-names></name><name><surname>Mehta</surname><given-names>P</given-names></name><name><surname>Curran</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>BGEM: an in situ hybridization database of gene expression in the embryonic and adult mouse nervous system</article-title><source>PLOS Biology</source><volume>4</volume><elocation-id>e86</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pbio.0040086</pub-id><pub-id pub-id-type="pmid">16602821</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marcucio</surname><given-names>RS</given-names></name><name><surname>Cordero</surname><given-names>DR</given-names></name><name><surname>Hu</surname><given-names>D</given-names></name><name><surname>Helms</surname><given-names>JA</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Molecular interactions coordinating the development of the forebrain and face</article-title><source>Developmental Biology</source><volume>284</volume><fpage>48</fpage><lpage>61</lpage><pub-id pub-id-type="doi">10.1016/j.ydbio.2005.04.030</pub-id><pub-id pub-id-type="pmid">15979605</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mougou-Zerelli</surname><given-names>S</given-names></name><name><surname>Thomas</surname><given-names>S</given-names></name><name><surname>Szenker</surname><given-names>E</given-names></name><name><surname>Audollent</surname><given-names>S</given-names></name><name><surname>Elkhartoufi</surname><given-names>N</given-names></name><name><surname>Babarit</surname><given-names>C</given-names></name><name><surname>Romano</surname><given-names>S</given-names></name><name><surname>Salomon</surname><given-names>R</given-names></name><name><surname>Amiel</surname><given-names>J</given-names></name><name><surname>Esculpavit</surname><given-names>C</given-names></name><name><surname>Gonzales</surname><given-names>M</given-names></name><name><surname>Escudier</surname><given-names>E</given-names></name><name><surname>Leheup</surname><given-names>B</given-names></name><name><surname>Loget</surname><given-names>P</given-names></name><name><surname>Odent</surname><given-names>S</given-names></name><name><surname>Roume</surname><given-names>J</given-names></name><name><surname>GÃ©rard</surname><given-names>M</given-names></name><name><surname>Delezoide</surname><given-names>A-L</given-names></name><name><surname>Khung</surname><given-names>S</given-names></name><name><surname>Patrier</surname><given-names>S</given-names></name><name><surname>Cordier</surname><given-names>M-P</given-names></name><name><surname>Bouvier</surname><given-names>R</given-names></name><name><surname>Martinovic</surname><given-names>J</given-names></name><name><surname>Gubler</surname><given-names>M-C</given-names></name><name><surname>Boddaert</surname><given-names>N</given-names></name><name><surname>Munnich</surname><given-names>A</given-names></name><name><surname>Encha-Razavi</surname><given-names>F</given-names></name><name><surname>Valente</surname><given-names>EM</given-names></name><name><surname>Saad</surname><given-names>A</given-names></name><name><surname>Saunier</surname><given-names>S</given-names></name><name><surname>Vekemans</surname><given-names>M</given-names></name><name><surname>AttiÃ©-Bitach</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>CC2D2A mutations in Meckel and Joubert syndromes indicate a genotype-phenotype correlation</article-title><source>Human Mutation</source><volume>30</volume><fpage>1574</fpage><lpage>1582</lpage><pub-id pub-id-type="doi">10.1002/humu.21116</pub-id><pub-id pub-id-type="pmid">19777577</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Muenke</surname><given-names>M</given-names></name><name><surname>Beachy</surname><given-names>PA</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Genetics of ventral forebrain development and holoprosencephaly</article-title><source>Current Opinion in Genetics &amp; Development</source><volume>10</volume><fpage>262</fpage><lpage>269</lpage><pub-id pub-id-type="doi">10.1016/S0959-437X(00)00084-8</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Noor</surname><given-names>A</given-names></name><name><surname>Windpassinger</surname><given-names>C</given-names></name><name><surname>Patel</surname><given-names>M</given-names></name><name><surname>Stachowiak</surname><given-names>B</given-names></name><name><surname>Mikhailov</surname><given-names>A</given-names></name><name><surname>Azam</surname><given-names>M</given-names></name><name><surname>Irfan</surname><given-names>M</given-names></name><name><surname>Siddiqui</surname><given-names>ZK</given-names></name><name><surname>Naeem</surname><given-names>F</given-names></name><name><surname>Paterson</surname><given-names>AD</given-names></name><name><surname>Lutfullah</surname><given-names>M</given-names></name><name><surname>Vincent</surname><given-names>JB</given-names></name><name><surname>Ayub</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>CC2D2A, encoding a coiled-coil and C2 domain protein, causes autosomal-recessive mental retardation with retinitis pigmentosa</article-title><source>American Journal of Human Genetics</source><volume>82</volume><fpage>1011</fpage><lpage>1018</lpage><pub-id pub-id-type="doi">10.1016/j.ajhg.2008.01.021</pub-id><pub-id pub-id-type="pmid">18387594</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Otto</surname><given-names>EA</given-names></name><name><surname>Tory</surname><given-names>K</given-names></name><name><surname>Attanasio</surname><given-names>M</given-names></name><name><surname>Zhou</surname><given-names>W</given-names></name><name><surname>Chaki</surname><given-names>M</given-names></name><name><surname>Paruchuri</surname><given-names>Y</given-names></name><name><surname>Wise</surname><given-names>EL</given-names></name><name><surname>Wolf</surname><given-names>MTF</given-names></name><name><surname>Utsch</surname><given-names>B</given-names></name><name><surname>Becker</surname><given-names>C</given-names></name><name><surname>NÃ¼rnberg</surname><given-names>G</given-names></name><name><surname>NÃ¼rnberg</surname><given-names>P</given-names></name><name><surname>Nayir</surname><given-names>A</given-names></name><name><surname>Saunier</surname><given-names>S</given-names></name><name><surname>Antignac</surname><given-names>C</given-names></name><name><surname>Hildebrandt</surname><given-names>F</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Hypomorphic mutations in meckelin (MKS3/TMEM67) cause nephronophthisis with liver fibrosis (NPHP11)</article-title><source>Journal of Medical Genetics</source><volume>46</volume><fpage>663</fpage><lpage>670</lpage><pub-id pub-id-type="doi">10.1136/jmg.2009.066613</pub-id><pub-id pub-id-type="pmid">19508969</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Panman</surname><given-names>L</given-names></name><name><surname>Zeller</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Patterning the limb before and after SHH signalling</article-title><source>Journal of Anatomy</source><volume>202</volume><fpage>3</fpage><lpage>12</lpage><pub-id pub-id-type="doi">10.1046/j.1469-7580.2003.00138.x</pub-id><pub-id pub-id-type="pmid">12587914</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reiter</surname><given-names>JF</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Tectonic, a novel regulator of the Hedgehog pathway required for both activation and inhibition</article-title><source>Genes &amp; Development</source><volume>20</volume><fpage>22</fpage><lpage>27</lpage><pub-id pub-id-type="doi">10.1101/gad.1363606</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roberson</surname><given-names>EC</given-names></name><name><surname>Dowdle</surname><given-names>WE</given-names></name><name><surname>Ozanturk</surname><given-names>A</given-names></name><name><surname>Garcia-Gonzalo</surname><given-names>FR</given-names></name><name><surname>Li</surname><given-names>C</given-names></name><name><surname>Halbritter</surname><given-names>J</given-names></name><name><surname>Elkhartoufi</surname><given-names>N</given-names></name><name><surname>Porath</surname><given-names>JD</given-names></name><name><surname>Cope</surname><given-names>H</given-names></name><name><surname>Ashley-Koch</surname><given-names>A</given-names></name><name><surname>Gregory</surname><given-names>S</given-names></name><name><surname>Thomas</surname><given-names>S</given-names></name><name><surname>Sayer</surname><given-names>JA</given-names></name><name><surname>Saunier</surname><given-names>S</given-names></name><name><surname>Otto</surname><given-names>EA</given-names></name><name><surname>Katsanis</surname><given-names>N</given-names></name><name><surname>Davis</surname><given-names>EE</given-names></name><name><surname>AttiÃ©-Bitach</surname><given-names>T</given-names></name><name><surname>Hildebrandt</surname><given-names>F</given-names></name><name><surname>Leroux</surname><given-names>MR</given-names></name><name><surname>Reiter</surname><given-names>JF</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>TMEM231, mutated in orofaciodigital and Meckel syndromes, organizes the ciliary transition zone</article-title><source>The Journal of Cell Biology</source><volume>209</volume><fpage>129</fpage><lpage>142</lpage><pub-id pub-id-type="doi">10.1083/jcb.201411087</pub-id><pub-id pub-id-type="pmid">25869670</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rubenstein</surname><given-names>JL</given-names></name><name><surname>Beachy</surname><given-names>PA</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title>Patterning of the embryonic forebrain</article-title><source>Current Opinion in Neurobiology</source><volume>8</volume><fpage>18</fpage><lpage>26</lpage><pub-id pub-id-type="doi">10.1016/s0959-4388(98)80004-4</pub-id><pub-id pub-id-type="pmid">9568388</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sang</surname><given-names>L</given-names></name><name><surname>Miller</surname><given-names>JJ</given-names></name><name><surname>Corbit</surname><given-names>KC</given-names></name><name><surname>Giles</surname><given-names>RH</given-names></name><name><surname>Brauer</surname><given-names>MJ</given-names></name><name><surname>Otto</surname><given-names>EA</given-names></name><name><surname>Baye</surname><given-names>LM</given-names></name><name><surname>Wen</surname><given-names>X</given-names></name><name><surname>Scales</surname><given-names>SJ</given-names></name><name><surname>Kwong</surname><given-names>M</given-names></name><name><surname>Huntzicker</surname><given-names>EG</given-names></name><name><surname>Sfakianos</surname><given-names>MK</given-names></name><name><surname>Sandoval</surname><given-names>W</given-names></name><name><surname>Bazan</surname><given-names>JF</given-names></name><name><surname>Kulkarni</surname><given-names>P</given-names></name><name><surname>Garcia-Gonzalo</surname><given-names>FR</given-names></name><name><surname>Seol</surname><given-names>AD</given-names></name><name><surname>OâToole</surname><given-names>JF</given-names></name><name><surname>Held</surname><given-names>S</given-names></name><name><surname>Reutter</surname><given-names>HM</given-names></name><name><surname>Lane</surname><given-names>WS</given-names></name><name><surname>Rafiq</surname><given-names>MA</given-names></name><name><surname>Noor</surname><given-names>A</given-names></name><name><surname>Ansar</surname><given-names>M</given-names></name><name><surname>Devi</surname><given-names>ARR</given-names></name><name><surname>Sheffield</surname><given-names>VC</given-names></name><name><surname>Slusarski</surname><given-names>DC</given-names></name><name><surname>Vincent</surname><given-names>JB</given-names></name><name><surname>Doherty</surname><given-names>DA</given-names></name><name><surname>Hildebrandt</surname><given-names>F</given-names></name><name><surname>Reiter</surname><given-names>JF</given-names></name><name><surname>Jackson</surname><given-names>PK</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Mapping the NPHP-JBTS-MKS protein network reveals ciliopathy disease genes and pathways</article-title><source>Cell</source><volume>145</volume><fpage>513</fpage><lpage>528</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2011.04.019</pub-id><pub-id pub-id-type="pmid">21565611</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Santagati</surname><given-names>F</given-names></name><name><surname>Rijli</surname><given-names>FM</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Cranial neural crest and the building of the vertebrate head</article-title><source>Nature Reviews. Neuroscience</source><volume>4</volume><fpage>806</fpage><lpage>818</lpage><pub-id pub-id-type="doi">10.1038/nrn1221</pub-id><pub-id pub-id-type="pmid">14523380</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schock</surname><given-names>EN</given-names></name><name><surname>Chang</surname><given-names>CF</given-names></name><name><surname>Struve</surname><given-names>JN</given-names></name><name><surname>Chang</surname><given-names>YT</given-names></name><name><surname>Chang</surname><given-names>J</given-names></name><name><surname>Delany</surname><given-names>ME</given-names></name><name><surname>Brugmann</surname><given-names>SA</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Using the avian mutant talpid 2 as a disease model for understanding the oral-facial phenotypes of Oral-facial-digital syndrome</article-title><source>Disease Models &amp; Mechanisms</source><volume>8</volume><fpage>855</fpage><lpage>866</lpage><pub-id pub-id-type="doi">10.1242/dmm.020222</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schock</surname><given-names>EN</given-names></name><name><surname>Brugmann</surname><given-names>SA</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Discovery, Diagnosis, and Etiology of Craniofacial Ciliopathies</article-title><source>Cold Spring Harbor Perspectives in Biology</source><volume>9</volume><elocation-id>a028258</elocation-id><pub-id pub-id-type="doi">10.1101/cshperspect.a028258</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schulte-Merker</surname><given-names>S</given-names></name><name><surname>Hammerschmidt</surname><given-names>M</given-names></name><name><surname>Beuchle</surname><given-names>D</given-names></name><name><surname>Cho</surname><given-names>KW</given-names></name><name><surname>De Robertis</surname><given-names>EM</given-names></name><name><surname>NÃ¼sslein-Volhard</surname><given-names>C</given-names></name></person-group><year iso-8601-date="1994">1994</year><article-title>Expression of zebrafish goosecoid and no tail gene products in wild-type and mutant no tail embryos</article-title><source>Development</source><volume>120</volume><fpage>843</fpage><lpage>852</lpage><pub-id pub-id-type="pmid">7600961</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shaheen</surname><given-names>R</given-names></name><name><surname>Faqeih</surname><given-names>E</given-names></name><name><surname>Seidahmed</surname><given-names>MZ</given-names></name><name><surname>Sunker</surname><given-names>A</given-names></name><name><surname>Alali</surname><given-names>FE</given-names></name><name><surname>AlQahtani</surname><given-names>K</given-names></name><name><surname>Alkuraya</surname><given-names>FS</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>A TCTN2 mutation defines a novel Meckel Gruber syndrome locus</article-title><source>Human Mutation</source><volume>32</volume><fpage>573</fpage><lpage>578</lpage><pub-id pub-id-type="doi">10.1002/humu.21507</pub-id><pub-id pub-id-type="pmid">21462283</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shaheen</surname><given-names>R</given-names></name><name><surname>Ansari</surname><given-names>S</given-names></name><name><surname>Mardawi</surname><given-names>EA</given-names></name><name><surname>Alshammari</surname><given-names>MJ</given-names></name><name><surname>Alkuraya</surname><given-names>FS</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Mutations in TMEM231 cause Meckel-Gruber syndrome</article-title><source>Journal of Medical Genetics</source><volume>50</volume><fpage>160</fpage><lpage>162</lpage><pub-id pub-id-type="doi">10.1136/jmedgenet-2012-101431</pub-id><pub-id pub-id-type="pmid">23349226</pub-id></element-citation></ref><ref id="bib59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname><given-names>UM</given-names></name><name><surname>Consugar</surname><given-names>M</given-names></name><name><surname>Tee</surname><given-names>LJ</given-names></name><name><surname>McKee</surname><given-names>BM</given-names></name><name><surname>Maina</surname><given-names>EN</given-names></name><name><surname>Whelan</surname><given-names>S</given-names></name><name><surname>Morgan</surname><given-names>NV</given-names></name><name><surname>Goranson</surname><given-names>E</given-names></name><name><surname>Gissen</surname><given-names>P</given-names></name><name><surname>Lilliquist</surname><given-names>S</given-names></name><name><surname>Aligianis</surname><given-names>IA</given-names></name><name><surname>Ward</surname><given-names>CJ</given-names></name><name><surname>Pasha</surname><given-names>S</given-names></name><name><surname>Punyashthiti</surname><given-names>R</given-names></name><name><surname>Malik Sharif</surname><given-names>S</given-names></name><name><surname>Batman</surname><given-names>PA</given-names></name><name><surname>Bennett</surname><given-names>CP</given-names></name><name><surname>Woods</surname><given-names>CG</given-names></name><name><surname>McKeown</surname><given-names>C</given-names></name><name><surname>Bucourt</surname><given-names>M</given-names></name><name><surname>Miller</surname><given-names>CA</given-names></name><name><surname>Cox</surname><given-names>P</given-names></name><name><surname>Algazali</surname><given-names>L</given-names></name><name><surname>Trembath</surname><given-names>RC</given-names></name><name><surname>Torres</surname><given-names>VE</given-names></name><name><surname>Attie-Bitach</surname><given-names>T</given-names></name><name><surname>Kelly</surname><given-names>DA</given-names></name><name><surname>Maher</surname><given-names>ER</given-names></name><name><surname>Gattone</surname><given-names>VH</given-names></name><name><surname>Harris</surname><given-names>PC</given-names></name><name><surname>Johnson</surname><given-names>CA</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>The transmembrane protein meckelin (MKS3) is mutated in Meckel-Gruber syndrome and the wpk rat</article-title><source>Nature Genetics</source><volume>38</volume><fpage>191</fpage><lpage>196</lpage><pub-id pub-id-type="doi">10.1038/ng1713</pub-id><pub-id pub-id-type="pmid">16415887</pub-id></element-citation></ref><ref id="bib60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Som</surname><given-names>PM</given-names></name><name><surname>Streit</surname><given-names>A</given-names></name><name><surname>Naidich</surname><given-names>TP</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Illustrated review of the embryology and development of the facial region, part 3: an overview of the molecular interactions responsible for facial development</article-title><source>AJNR. American Journal of Neuroradiology</source><volume>35</volume><fpage>223</fpage><lpage>229</lpage><pub-id pub-id-type="doi">10.3174/ajnr.A3453</pub-id><pub-id pub-id-type="pmid">23557958</pub-id></element-citation></ref><ref id="bib61"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Srour</surname><given-names>M</given-names></name><name><surname>Hamdan</surname><given-names>FF</given-names></name><name><surname>Schwartzentruber</surname><given-names>JA</given-names></name><name><surname>Patry</surname><given-names>L</given-names></name><name><surname>Ospina</surname><given-names>LH</given-names></name><name><surname>Shevell</surname><given-names>MI</given-names></name><name><surname>DÃ©silets</surname><given-names>V</given-names></name><name><surname>Dobrzeniecka</surname><given-names>S</given-names></name><name><surname>Mathonnet</surname><given-names>G</given-names></name><name><surname>Lemyre</surname><given-names>E</given-names></name><name><surname>Massicotte</surname><given-names>C</given-names></name><name><surname>Labuda</surname><given-names>D</given-names></name><name><surname>Amrom</surname><given-names>D</given-names></name><name><surname>Andermann</surname><given-names>E</given-names></name><name><surname>SÃ©bire</surname><given-names>G</given-names></name><name><surname>Maranda</surname><given-names>B</given-names></name><collab>FORGE Canada Consortium</collab><name><surname>Rouleau</surname><given-names>GA</given-names></name><name><surname>Majewski</surname><given-names>J</given-names></name><name><surname>Michaud</surname><given-names>JL</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Mutations in TMEM231 cause Joubert syndrome in French Canadians</article-title><source>Journal of Medical Genetics</source><volume>49</volume><fpage>636</fpage><lpage>641</lpage><pub-id pub-id-type="doi">10.1136/jmedgenet-2012-101132</pub-id><pub-id pub-id-type="pmid">23012439</pub-id></element-citation></ref><ref id="bib62"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tallila</surname><given-names>J</given-names></name><name><surname>Jakkula</surname><given-names>E</given-names></name><name><surname>Peltonen</surname><given-names>L</given-names></name><name><surname>Salonen</surname><given-names>R</given-names></name><name><surname>KestilÃ¤</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Identification of CC2D2A as a Meckel syndrome gene adds an important piece to the ciliopathy puzzle</article-title><source>American Journal of Human Genetics</source><volume>82</volume><fpage>1361</fpage><lpage>1367</lpage><pub-id pub-id-type="doi">10.1016/j.ajhg.2008.05.004</pub-id><pub-id pub-id-type="pmid">18513680</pub-id></element-citation></ref><ref id="bib63"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thibert</surname><given-names>C</given-names></name><name><surname>Teillet</surname><given-names>MA</given-names></name><name><surname>Lapointe</surname><given-names>F</given-names></name><name><surname>Mazelin</surname><given-names>L</given-names></name><name><surname>Le Douarin</surname><given-names>NM</given-names></name><name><surname>Mehlen</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Inhibition of neuroepithelial patched-induced apoptosis by sonic hedgehog</article-title><source>Science</source><volume>301</volume><fpage>843</fpage><lpage>846</lpage><pub-id pub-id-type="doi">10.1126/science.1085405</pub-id><pub-id pub-id-type="pmid">12907805</pub-id></element-citation></ref><ref id="bib64"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tobin</surname><given-names>JL</given-names></name><name><surname>Beales</surname><given-names>PL</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>The nonmotile ciliopathies</article-title><source>Genetics in Medicine</source><volume>11</volume><fpage>386</fpage><lpage>402</lpage><pub-id pub-id-type="doi">10.1097/GIM.0b013e3181a02882</pub-id><pub-id pub-id-type="pmid">19421068</pub-id></element-citation></ref><ref id="bib65"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xavier</surname><given-names>GM</given-names></name><name><surname>Seppala</surname><given-names>M</given-names></name><name><surname>Barrell</surname><given-names>W</given-names></name><name><surname>Birjandi</surname><given-names>AA</given-names></name><name><surname>Geoghegan</surname><given-names>F</given-names></name><name><surname>Cobourne</surname><given-names>MT</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Hedgehog receptor function during craniofacial development</article-title><source>Developmental Biology</source><volume>415</volume><fpage>198</fpage><lpage>215</lpage><pub-id pub-id-type="doi">10.1016/j.ydbio.2016.02.009</pub-id><pub-id pub-id-type="pmid">26875496</pub-id></element-citation></ref><ref id="bib66"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Young</surname><given-names>NM</given-names></name><name><surname>Chong</surname><given-names>HJ</given-names></name><name><surname>Hu</surname><given-names>D</given-names></name><name><surname>HallgrÃ­msson</surname><given-names>B</given-names></name><name><surname>Marcucio</surname><given-names>RS</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Quantitative analyses link modulation of sonic hedgehog signaling to continuous variation in facial growth and shape</article-title><source>Development</source><volume>137</volume><fpage>3405</fpage><lpage>3409</lpage><pub-id pub-id-type="doi">10.1242/dev.052340</pub-id><pub-id pub-id-type="pmid">20826528</pub-id></element-citation></ref><ref id="bib67"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zaghloul</surname><given-names>NA</given-names></name><name><surname>Brugmann</surname><given-names>SA</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>The emerging face of primary cilia</article-title><source>Genesis</source><volume>49</volume><fpage>231</fpage><lpage>246</lpage><pub-id pub-id-type="doi">10.1002/dvg.20728</pub-id></element-citation></ref><ref id="bib68"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhulyn</surname><given-names>O</given-names></name><name><surname>Li</surname><given-names>D</given-names></name><name><surname>Deimling</surname><given-names>S</given-names></name><name><surname>Vakili</surname><given-names>NA</given-names></name><name><surname>Mo</surname><given-names>R</given-names></name><name><surname>Puviindran</surname><given-names>V</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Short Article</article-title><source>Developmental Cell</source><volume>29</volume><fpage>241</fpage><lpage>249</lpage><pub-id pub-id-type="doi">10.1016/j.devcel.2014.03.002</pub-id></element-citation></ref></ref-list></back><sub-article article-type="decision-letter" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.68558.sa1</article-id><title-group><article-title>Decision letter</article-title></title-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Devenport</surname><given-names>Danelle</given-names></name><role>Reviewing Editor</role><aff><institution>Princeton University</institution><country>United States</country></aff></contrib></contrib-group><contrib-group><contrib contrib-type="reviewer"><name><surname>Stottmann</surname><given-names>Rolf W</given-names></name><role>Reviewer</role><aff><institution>Nationwide Children's Hospital</institution><country>United States</country></aff></contrib></contrib-group></front-stub><body><boxed-text id="box1"><p>In the interests of transparency, eLife publishes the most substantive revision requests and the accompanying author responses.</p></boxed-text><p><bold>Acceptance summary:</bold></p><p>This paper will be of interest to developmental biologists, cilia researchers and those interested in the etiology of syndromes called ciliopathies. The significance of the study is that it reveals a mechanism by which mutation of proteins that organize the ciliary transition zone can lead to craniofacial patterning defects. Extensive genetic data support the conclusion that loss of these transition zone proteins leads to apoptotic cell death and, ultimately, the resulting smaller structures of the facial midline by reducing Sonic Hedgehog signaling.</p><p><bold>Decision letter after peer review:</bold></p><p>Thank you for submitting your article &quot;Ciliary Hedgehog signaling regulates cell survival to build the facial midline&quot; for consideration by <italic>eLife</italic>. Your article has been reviewed by 2 peer reviewers, and the evaluation has been overseen by a Reviewing Editor and Piali Sengupta as the Senior Editor. The following individual involved in review of your submission has agreed to reveal their identity: Rolf W Stottmann (Reviewer #1).</p><p>The reviewers have discussed their reviews with one another, and the Reviewing Editor has drafted this to help you prepare a revised submission.</p><p>Essential revisions:</p><p>1) The authors observed decreased apoptosis in Tctn2 mutants following reduction of Ptch1 gene dosage but did not see rescue of Gli1 or Shh gene expression in the ventral telencephalon. Based upon these results, the authors propose that it is noncanonical (GLI-independent) PTCH proapoptotic activity that is responsible for the defect, but further evidence is needed to support the claim. Might there be a SHH-PTCH-GLI transcriptional effect that contributes to the rescue but is not detectable by monitoring only Gli1 and Shh expression? Can an attempt be made to directly rule out SHH signaling to GLI effectors? Perhaps reducing Sufu in the Tctn-/- model and testing for rescue of apoptosis vs. target gene expression?</p><p>2) If the effect is indeed GLI-independent, some explanation of how primary cilium dysfunction impacts SHH control of PTCH dependence receptor activity is needed, since PTCH-mediated activation of apoptosis likely occurs from the plasma membrane, and not ciliary membrane. Incorporating this into the model in figure 6 would be helpful.</p><p>3) The neural crest cells/ mesenchyme make up the vast majority of the cells populating the midface. While these would presumably be at least some of the cells dying there is very little discussion or direct measurement of these cells.</p><p>4) Including information about the spatiotemporal expression of the TZ genes in the relevant craniofacial stages would be helpful for interpreting phenotypes.</p><p>5) We recommend that all quantifications are shown as in Figure 1 where the data points are included in the graph. Furthermore, p-values should be stated rather than coded with *, **, *** etc.</p><p>6) The Discussion reads (line 317), &quot;Our data are consistent with a role of PTCH1 in promoting apoptosis in the neuroectoderm and facial ectoderm which is inhibited by prechordal plate-produced SHH. In the absence of TCTN2, the prechordal plate does not produce SHH, releasing PTCH1 to promote apoptosis in the midline and resulting in midface hypoplasia.&quot; However, the data in Figure 2A show that the prechordal plate does continue to express SHH in TCTN2 mutants. Rather, the downstream pathway is affected. This needs to be clarified in the overall model.<italic>Reviewer #1:</italic></p><p>The data presented in this paper support the conclusions drawn. The analyses are standard in the field, well powered and robust. The phenotypes (both gross and molecular) are fairly easy to appreciate. This paper does indeed come to a conclusion about what might be causing the mid facial deficits in the transition zone gene mutant mice: namely, large increased in cell death which are, at least in part, mediated through the Ptc Hh receptor.</p><p>Strengths:</p><p>Looking at the embryo at the early head fold stages is a nice insight and is a bit earlier than many craniofacial analyses. This represents a nice grounding of this work in fundamentals of embryology.</p><p>Significant genetics are done but only briefly discussed (the conditional ablations). These are important as they clearly help guide the authors to the presented model.</p><p>Weaknesses:</p><p>The neural crest cells/ mesenchyme make up the vast majority of the cells populating the midface. While these would presumably be at least some of the cells dying there is very little discussion or direct measurement of these cells.</p><p>The implication of this model is a signal(s) from the ectoderm and the neural ectoderm promoting neural crest cell growth. Further explanation or exploration of this would be a great addition to really understanding the phenotypes.</p><p><italic>Reviewer #2:</italic></p><p>This manuscript reveals a crucial role for primary cilia transition zone components in regulation of proper patterning of the facial midline. Using a genetic knockout strategy, the authors show that loss of transition zone components that are commonly mutated in the ciliopathy Meckel Syndrome (MKS) lead to hypotelorism (narrowing at the facial midline). These mutations were shown to reduce Sonic Hedgehog (SHH) signaling in the prechordal plate, which increased apoptosis in the facial ectoderm and ventral telencephalon. The increased apoptosis and midline defects could be rescued by reducing gene dosage of the SHH receptor and negative signaling regulator Patched (PTCH), suggesting that compromised SHH signaling leads to craniofacial malformation in this genetic context.</p><p>Hypotelorism is a common presentation in ciliopathy disorders, but the underlying mechanism has not been clear. The results provided in this study support that pattern disruption likely results from apoptosis of cells in the developing midline neuroectoderm and facial endoderm resulting from reduced SHH-mediated control of dependence receptor activity by PTCH. Intriguingly, target gene analysis in the ventral telencephalon suggests that PTCH signaling to GLI is unlikely to control cell survival during midface development, leading the authors to propose that the pro-apoptotic role of PTCH is the main phenotypic driver in this tissue context. The genetic experiments are clearly presented, and conclusions are supported by the data. The key conclusion of the study â that attenuation of transcription-independent SHH-PTCH signaling is responsible for midline defects â would be strengthened by some supporting mechanistic interrogation (and/or additional genetic interrogation). Monitoring caspase activity suggests that apoptosis is impacted, but the conclusion that there is unlikely to be a GLI-dependent transcriptional component contributing to patterning alteration is not appropriately supported.</p></body></sub-article><sub-article article-type="reply" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.68558.sa2</article-id><title-group><article-title>Author response</article-title></title-group></front-stub><body><disp-quote content-type="editor-comment"><p>Essential revisions:</p><p>1) The authors observed decreased apoptosis in Tctn2 mutants following reduction of Ptch1 gene dosage but did not see rescue of Gli1 or Shh gene expression in the ventral telencephalon. Based upon these results, the authors propose that it is noncanonical (GLI-independent) PTCH proapoptotic activity that is responsible for the defect, but further evidence is needed to support the claim. Might there be a SHH-PTCH-GLI transcriptional effect that contributes to the rescue but is not detectable by monitoring only Gli1 and Shh expression? Can an attempt be made to directly rule out SHH signaling to GLI effectors? Perhaps reducing Sufu in the Tctn-/- model and testing for rescue of apoptosis vs. target gene expression?</p></disp-quote><p>As the reviewers points out, we include in the Discussion comment on the possibility that SHH relieves the proapoptotic activity of PTCH to support growth of the facial midline. However, other possibilities, including the idea that transcriptional effects independent of general HH targets such as Gli1, are not disproven. Therefore, we include discussion of these other possibilities in the revised Discussion.</p><p>As suggested by the reviewers, we attempted to rule out the involvement of SHH signaling to GLI effectors in the survival of midline cells. Unfortunately, generating <italic>Tctn2 Sufu</italic> double mutant mice was not feasible in the time allotted for the revision process. We reasoned that SAG, a Smoothened agonist, should activate GLI transcriptional effects but not antagonize the biochemical functions of PTCH, whereas SHH should activate GLI transcriptional effects and antagonize the biochemical functions of PTCH. Thus, an alternative test of whether SHH signaling to GLI effectors is critical for the survival of midline cells is to assess whether both SAG and SHH have similar or distinct effects on midline cell survival. If GLI activation is sufficient to promote midline cell survival, both SHH and SAG should increase cell survival in wild-type embryos but not in <italic>Tctn2</italic> mutant embryos. If, instead, biochemical inhibition of PTCH is critical for midline cell survival, SHH (an inhibitor of PTCH) should increase cell survival even in <italic>Tctn2</italic> mutant embryos, whereas SAG (which acts downstream of PTCH) should not. Rescue of <italic>Tctn2</italic><sup>-/-</sup> cell viability by SHH but not SAG would further suggest that unopposed PTCH1 activity inhibits cell viability in the absence of transition zone function.</p><p>To attempt to test these hypotheses, we employed a Whole Embryo Culture (WEC) system to culture of E8.5 mouse embryos ex utero in WEC-grade rat serum. We successfully cultured E8.5 embryos for 24 hours. Cultured embryos developed similarly to in utero embryos, as determined by turning, closure of the neural tube and looping of the heart tube.</p><p>Despite the success establishing the WEC system, it was unclear whether SAG or SHH added to the medium will access HH responsive cells within the embryo. Unfortunately, we were unable to detect robust induction of <italic>Ptch1</italic> and <italic>Gli1</italic> over a range of SHH and SAG concentrations. Thus, as directed by the reviewers, we have made an attempt to rule out SHH signaling to GLI effectors, but have not definitively proven that GLI effectors are uninvolved in inhibiting midline apoptosis. Therefore, we have revised the Discussion to acknowledge the possibility that SHH signaling to GLI effectors may contribute to midline growth in the craniofacial complex. Some of these changes are incorporated in the penultimate paragraph of the Discussion.</p><disp-quote content-type="editor-comment"><p>2) If the effect is indeed GLI-independent, some explanation of how primary cilium dysfunction impacts SHH control of PTCH dependence receptor activity is needed, since PTCH-mediated activation of apoptosis likely occurs from the plasma membrane, and not ciliary membrane. Incorporating this into the model in figure 6 would be helpful.</p></disp-quote><p>We concur with the reviewers that PTCH-mediated activation of apoptosis likely occurs at the plasma membrane. We propose that primary cilium dysfunction impacts PTCH-mediated apoptosis by controlling expression of SHH in the ventral telencephalon. Although beyond the scope of this manuscript focused on craniofacial development, we speculate that in other tissues, such as the developing spinal cord, reduced SHH expression caused by ciliary dysfunction will similarly cause increased apoptosis. In yet other tissues, such as the limb bud (where ciliary dysfunction does not alter <italic>Shh</italic> expression), we predict that ciliary dysfunction will not cause increased apoptosis. Thus, ciliary dependence of <italic>Shh</italic> expression may be a determinant of tissues in which ciliary dysfunction result in increased apoptosis. We now include a brief description of these possibilities in the new seventh paragraph of the Discussion.</p><p>As suggested by the reviewers, we also revised model in figure 6 to highlight that PTCH-mediated activation of apoptosis could initiate from the plasma membrane. In addition, we now include explicit description of this possibility in the penultimate paragraph of the Results section.</p><disp-quote content-type="editor-comment"><p>3) The neural crest cells/ mesenchyme make up the vast majority of the cells populating the midface. While these would presumably be at least some of the cells dying there is very little discussion or direct measurement of these cells.</p></disp-quote><p>We apologize for our lack of clarity. We measured cell death (via TUNEL, cleaved Caspase-3 staining, and cleaved Caspase-9 staining) and proliferation (via phospho-Histone H3 staining) in the midface. Further quantification has been added in review. and show that there is a statistically significant increase in cell death in the mesenchyme (as well as the brain and midline ectoderm) at E9.5. The increase in cell death in the mesenchyme is now also discussed in the revised text (including in the penultimate paragraph of the Results section) and Figure 4.</p><disp-quote content-type="editor-comment"><p>4) Including information about the spatiotemporal expression of the TZ genes in the relevant craniofacial stages would be helpful for interpreting phenotypes.</p></disp-quote><p>Prior spatiotemporal expression of transition zone genes has revealed that these genes are widely expressed throughout the stages analyzed here. We have included text that references our and othersâ previous studies that detail expression pattern of transition zone genes at relevant stages for our current study. The revised text is included in the second paragraph of page 7 in the Results section.</p><disp-quote content-type="editor-comment"><p>5) We recommend that all quantifications are shown as in Figure 1 where the data points are included in the graph. Furthermore, p-values should be stated rather than coded with *, **, *** etc.</p></disp-quote><p>As recommended by the reviewers, we have changed all quantifications to explicitly show all data points, as previously done for Figure 1. In addition, we have now included stated p-values in all figures.</p><disp-quote content-type="editor-comment"><p>6) The Discussion reads (line 317), &quot;Our data are consistent with a role of PTCH1 in promoting apoptosis in the neuroectoderm and facial ectoderm which is inhibited by prechordal plate-produced SHH. In the absence of TCTN2, the prechordal plate does not produce SHH, releasing PTCH1 to promote apoptosis in the midline and resulting in midface hypoplasia.&quot; However, the data in Figure 2A show that the prechordal plate does continue to express SHH in TCTN2 mutants. Rather, the downstream pathway is affected. This needs to be clarified in the overall model.</p></disp-quote><p>Thank you for pointing out this error. We have revised the text (in the second paragraph of page 14) to state, âIn the absence of TCTN2, the ventral telencephalon does not produce SHH, releasing PTCH1 to promote apoptosis in the midline and resulting in midface hypoplasia.â</p></body></sub-article></article>